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Biomedical parameters are critical for diseases prognosis, diagnosis and therapy.  
Many research groups have dedicated their studies to develop analytical instrumentation 
and apply analytical methods to determine biomedical parameters that have the potential 
to help with disease control and increase public health. This dissertation focuses on three 
major aspects of analytical strategies development and applications: 1) detection of pH 
changes caused by nanotoxicity (induced by TiO2 nanoparticles) using newly developed 
micro-pH sensor, 2) quantification of renal cell carcinoma (RCC) biomarkers by high-
performance liquid chromatography – tandem mass spectrometry (HPLC-MS/MS), and 3) 
nuclear magnetic resonance (NMR) studies of porous wall hollow glass microspheres 
(PWHGMs) that have the potential to be used as drug delivery carriers. Firstly, a dual-
core fiber-optic pH micro-probe was developed which can be used within the biologically 
relevant pH range from 6.20 – 7.92 (R2 = 0.9834). Secondly, a targeted HPLC-MS/MS 
protocol was developed to simultaneously monitor four urinary biomarkers for RCC and 
applied to human urine specimen analysis. Thirdly, a vacuum-based loading system was 
developed to charge PWHGMs with specific materials followed by a washing procedure. 
Immiscible binary model systems (n-dodecane/water and chloroform/water) as well as 
isopropanol- acetic acid esterification and the hydrolysis of isopropyl acetate were 
investigated to obtain NMR evidence for material loading into PWHGMs and their 
subsequent release into the surrounding solutions. In addition, microspheres loaded with 
H2O were suspended in D2O to obtain quantitative information about the release kinetics 
from PWHGMs. The results demonstrate that NMR is a particularly useful tool to study 
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1.1. ADVANCED ANALYTICAL STRATEGIES IN BIOMEDICAL STUDIES 
Biomedical studies are a dynamic and challenging area that is highly relevant to 
the understanding and treatment of human diseases. It involves research from disease 
diagnosis to therapy, focusing on the interaction between cells, molecules, and organs. 
Scientists have been contributing with every possible effort to solve biomedical issues 
and problems with various analytical instruments and techniques. Conventional analytical 
instruments, such as high-performance liquid chromatography coupled with mass 
spectrometry (HPLC-MS) or tandem mass spectrometry (HPLC-MS/MS), gas 
chromatography coupled with mass spectrometry (GC-MS) or tandem mass spectrometry 
(GC-MS/MS), nuclear magnetic resonance (NMR) spectroscopy and others have been 
widely applied in biomedical studies. For example, with its advantages of high efficiency, 
high throughput, and ultra-high sensitivity, HPLC-MS and HPLC-MS/MS are leading the 
way in studies for antihypertensive treatment [1], proteomics [2], metabolomics [3], and 
biomarker discovery [4]. GC-MS and GC-MS/MS are state-of-art instrumentation 
techniques that are applied in many areas of biomedical studies such as pharmacokinetics 
[5], drug delivery [6]. NMR spectroscopy is a very powerful tool for elucidating the 
structures and dynamics of both small and large molecules (even macro-molecules) [7]. 
In biomedical research and medical diagnostics, NMR spectroscopy has been widely used 
in the form of magnetic resonance imaging (MRI), which offers valuable information on 
disease diagnosis and evaluation [8]. Although all of these techniques have their specific 
advantages and disadvantages, several studies report how they can be applied to
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complement each other in biomedical studies [9-11]. Meanwhile, there are emerging new 
and innovative technologies and techniques that are intended to solve very specific 
biomedical problems. Fiber optic sensors (FOS) for example have been attracting 
considerable interest due to the effect that physical or chemical parameters can change 
the properties of light propagating in the fiber. The high elasticity and small size allow 
designing miniaturized FOS with metrological characteristics (e.g., accuracy, sensitivity, 
and frequency response) adequate for most common biomedical applications [12].  
1.2.IMPORTANCE OF NICHE CELLULAR ENVIRONMENT PH 
MEASUREMENT IN DISEASE DIAGNOSIS 
The human body is designed to maintain a very delicate pH balance in its fluid, 
tissues and systems. Even though most biological reactions essential to life take place in 
an aqueous environment, the blood plasma and interstitial fluids surrounding the cells are 
most sensitive to pH imbalance. When pH of these fluids is maintained within a narrow 
range of 7.35 to 7.45, our body’s immune system is operating in optimal conditions and is 
able to fight off illness and disease. Moreover, enzymes that catalyze the chemical 
reactions of life require a specific pH in order to function, and if the pH is imbalanced 
significantly, biochemical like proteins can be denatured and become non-functional, 
resulting in diseases or death. Organisms are composed of many different type of cells 
and one of the most important mechanism that helps pH balance is the buffer system 
inside the cytoplasm of cells [13]. To better and thorough understand diseases and 
biomedical cases, studies can be done narrowly down to cellular level. Therefore, 
measurement of parameters at cellular level is highly important. Among all cellular 
3 
 
parameters, cytosolic proton concentration (e.g. pH) has been acknowledged as an 
indicator for fundamental cellular events, because many biology processes are pH 
sensitive, such as cell differentiation, division, migration and death [14-16]. In the 
complement, cellular pH will change or dysregulate if cells undergo abnormal processes, 
such as external stimuli (i.e. toxic materials), cancer development. Therefore, pH 
measurement is critical to understand cell behaviors and predict any irregular events. 
Cellular pH is regulated through different antiports and symports [17]. The NHEs are a 
family of membrane proteins and play a crucial role in many biological processes [18], 









symports, are also essential for intracellular pH regulation. The dysfunction of these 
regulators will lead to pH dysregulation and thus cause disease or death. Therefore, 
accurate, real-time pH measurements are key to further understand cell behaviors, and 
eventually benefit disease prognosis and treatment. 
1.3.THE IMPORTANCE OF BIOMARKERS FOR DIAGNOSIS AND THERAPY 
The definition of biomarker has evolved over the past decades, and the World 
Health Organization has now broadly defined them as “A biomarker is any substance, 
structure or process that can be measured in the body or its products and influence or 
predict the incidence of outcome or disease” [19]. More specific for medical studies, the 
National Cancer Institute has defined a biomarker as “a biological molecule found in 
blood, other body fluids, or tissues that is a sign of a normal or abnormal process or of a 
condition or disease”. In clinical studies, biomarkers are often identified as indicators of 
the presence, severity, or state of a disease, which renders them important in medical 
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research. As such, biomarkers typically differentiate an affected patient from a person 
without the disease. Consequently, biomarkers can be present in many different forms, 
including particular proteins or peptides [20-24], antibodies [25-28], cell types [29-32], 
metabolites [33-36], lipids [37-39], hormones [40-42], enzyme levels [43-45], and 
physiological states [46, 47]. However, biomarkers can also be used to evaluate the 
effectiveness of therapies with regard to mediating the adverse effects of a disease. For 
example, using biomarkers to monitor the response of patients to a specific drug, it is 
possible to determine whether the treatment of the disease is effective. This information 
could result in a valuable early detection of negative drug response or could potentially 
bring enhancement in drug efficiency to patients. Ultimately and most importantly, 
biomarkers are used to detect changes in physiological conditions that correlate with the 
risk, progression, or remediation of a disease [23, 48-50]. In addition to prognosis and 
diagnosis of biomarkers, they can also be used for local and targeted therapy. For 
example, interleukin-33 (IL-33) is a functional ligand for ST2, a member of the 
interleukin-1 receptor family. IL-33/ST2 is a promising cardiovascular biomarker with a 
newly proposed mechanism of communication between intramyocardial fibroblast–
cardiomyocyte [51]. This may be a therapeutic target to slow down the rate of further 
heart failure. Another example is Bevacizumab, a MoAb binding vascular endothelial 
growth factor (VEGF) that has been reported as an effective molecule for treatment of 
ovarian cancer [52]. Therefore, biomarkers can be directly delivered to target tissues or 
body sites for disease therapeutic effects to obtain high efficiency disease treatments. 
Many efforts have been devoted to the discovery and determination of biomarkers 
in biological samples and tissues [53]. Mass spectrometry (MS) has been extensively 
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used as a diagnostic tool in clinical laboratories for many decades. When it is applied in 
biomarker discovery, it is largely used in proteomic studies [54, 55]. MS can provide 
accurate mass to charge ratios for different fragments of biomarkers. In addition, different 
types of mass analyzers can further assess each fragment, providing valuable proteomic-
pattern information that makes it possible to discriminate between diseased patients and 
healthy individuals. Other analytical techniques such as nuclear magnetic resonance 
(NMR) spectroscopy [56, 57], are also being used in biomarker discovery and 
quantification. 
1.4.THE DEVELOPMENT OF DRUG DELIVERY SYSTEM FOR 
IMPROVEMENT IN DISEASE THERAPY 
Drugs have been used to improve human health for many centuries if not 
millennia. The application of targeted drug delivery to specific infected sites has 
significantly changed in the past decades and is expected to have an even greater impact 
in the future. Targeted drug delivery systems are engineered technologies for specific and 
controlled drug delivery of therapeutic agents [58]. The development of drug delivery 
system is to reduce the side effects that drugs may have on healthy tissues, which often 
prevents the optimal medication for diseases such as cancer [59], neurodegenerative 
disease [60], and infectious diseases [61]. Traditional drugs may be taken orally, by 
inhalation or injection, or by absorption through the skin. Each method has advantages 
and disadvantages and, for a specific disease, not all methods can be applied for the 
available medication. Therefore, improvements of current delivery methods, or targeted 
delivery alternatives to these methods are of particularly interest to research and 
development. Nanotechnology is emerging as a novel platform for drug delivery and is 
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widely expected to change the landscape of biotechnology for the foreseeable future [62-
64]. Several delivery vehicles have been designed based on nanomaterials such as 
liposomes [65], polymers [66], nanotubes [67], and nanoparticles [68]. The newly 
developed vehicles for drug delivery should achieve several goals such as improving the 
delivery of poorly water-soluble drugs [69], the delivery of drugs to target sites or 
specific tissues [70], or the co-delivery of two or more drugs for combination therapy 
[71]. With regards to all of these merits, the newly designed drug delivery systems aim to 
largely improve the accuracy of delivery, the efficiency of therapies, and the time for 
recovery.  
1.5.APPLICATIONS OF MICROSPHERES IN CANCER TREATMENT 
Cancer is a disease in which abnormal cells grow fast and have the potential to 
invade other tissues or sites. The American Cancer Society reported that cancer is the 
second leading cause of death and it has been a worldwide disease that has attracted 
researchers’ attention for many several decades. Scientists have been contributing with 
every effort to find solutions for cancer treatments. Traditional cancer treatments with 
anticancer drugs have limitations because of their lack of selectivity for tumor tissue and 
often cause side effects resulting in reduced cure rates. Consequently, targeted therapies 
have become more significant for cancer treatment, which can reduce side effects and 
increase the effectiveness of cure. Cancer microspheres technology is emerging as a 
novel and up-to-date methodology in cancer treatment [72]. There are many advantages 
of microspheres, such as targeted delivery of drugs and treatment directly at desired sites. 
The targeted treatment is achieved by a very specific size of the microspheres relative to 
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the blood vessels of the targeted organ. For example, glass microspheres are used as 
vehicles to treat liver cancer with radiation. Yttrium-90 (Y-90) doped glass microspheres 
are increasingly used for liver cancer treatment [73, 74]. Y-90 microspheres have two 
forms: one is composed of tiny glass beads embedded with Y-90 (TheraSphere®) 
whereas the other is composed of tiny polymer beads filled with Y-90 (SIR-Spheres®). 
Both types of microspheres have been approved by the Food and Drug Administration 
(FDA) in 1999 and 2002 respectively [75]. They function as emitters of beta particles that 
penetrate 2.5 mm into the surrounding tissue and have 2.6-day half-life [76]. The sizes of 
Y-90 microspheres are typically 20 – 60 µm in diameter. They are applied by infusion via 
the hepatic artery and preferentially lodge in the tumor’s blood vessels, while sparing 
normal tissue which typically has larger blood vessels [77]. Microspheres have also been 
used for other types of cancers, such as breast cancer [78], colorectal cancer [79], lung 
cancer [80], ovarian cancer [81], bladder cancer [82] and others. Therefore, microspheres 
are an efficient carrier system for treatments of many types of cancers and can be tailored 
for very specific targeted treatments. 
1.6.POROUS WALL HOLLOW GLASS MICROSPHERES  
Biomaterials have been playing a pivotal role in biomedical research during 
recent years. Among the different types of biomaterials, certain glass materials are known 
to be biocompatible and have been used safely in applications requiring permanent 
implantation [83]. Since the first generation of such glass materials was developed in the 
1960s, they have been widely used in dental [84], orthopedic [85, 86], and tissue 
engineering applications [87, 88]. Recently, more studies have focused on the “third 
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generation” of glass materials, which are designed for therapies to achieve tissue 
regeneration and tissue repair without invasive surgery [89]. Glass materials have also 
been proposed as delivery system for drugs [90], growth factors [91], and proteins [92]. 
Biocompatible glass microspheres are spherical particles with diameters in the 
micrometer range. Recently, porous-wall hollow glass microspheres (PWHGMs) have 
attracted the interest of researchers due to their specifically engineered hollow-cavity 
SiO2 structure that consists of 1-µm thick porous walls [93]. The centers of the hollow 
cavities can be filled with different materials for various applications. PWHGMs were 
originally fabricated to be used by the Department of Energy (DOE) for national security 
and energy applications, as well as waste management and environmental remediation 
projects [93, 94]. Because of their unique properties, such as high and controllable 
permeability, low density, the storage cavity and large surface area, PWHGMs have been 
used in storage batteries [95], material adsorption [96], gas sensors [97], hydrogen 
storage [98], security technology [99] and others. The pores (i.e., open channels) in the 
wall and the hollow cavities of PWHGMs render them a potential vehicle for drug 
delivery [100], and more recent studies have reported the use of PWHGMs for 
biomedical applications, especially for cancer therapy [100, 101]. In addition to drug 
delivery applications, the hollow cavities of microspheres can serve as containers for 
biomarkers to achieve targeted delivery for specific prognosis and diagnosis of diseases. 
1.7.NUCLEAR MAGNETIC RESONANCE (NMR) SIGNIFICANCE IN THE 
STUDIES OF PWHGMS  
PWHGMs were characterized largely by optical microscopy, scanning electron 
microcopy (SEM) [102], transmission electron microcopy (TEM) [103], confocal laser 
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scanning microscopy (CLSM) [104], and dynamic light scattering [104]. However, these 
techniques only provided the characterization of the surface, shell thickness, and pore 
sizes of PWHGMs. To obtain information about what has been loaded inside the cavities 
of PWHGMs for targeted biomarker and drug delivery, an analytical technique is needed 
that can provide specific information about the loaded materials and its releasing kinetics. 
NMR spectroscopy is one of the most powerful analytical tools and it is widely used in 
pharmaceutical [105], biomedical [106] and chemical investigations in industry and 
academia. Unequivocal analytical evidence can be provided from NMR spectra, such as 
chemical structures, dynamics, and conformational information [107], which makes 
NMR stand out ahead of many other techniques. In addition, most NMR techniques are 
inherently quantitative as signal intensities are directly related to the number of nuclei 
under investigation. Unlike other commonly used analytical techniques, sample 
preparation for NMR spectroscopy is generally simple and no sample separation such as 
in high performance liquid chromatography (HPLC) or gas chromatography (GC), is 
needed. Moreover, NMR is a non-destructive technique and thus is most suitable for 
kinetic studies and analyses [108]. NMR spectroscopic techniques have been widely used 
in drug discovery, where detailed insights into interactions between molecules and a 
matrix is desired [109]. However, no NMR study on PWHGMs and their potential use in 
targeted drug or biomarker delivery is known. With the fundamental advantages of NMR 
and its versatility, more valuable information can be acquired from NMR spectra to fully 




This work aims to utilize several advanced analytical techniques, including 
traditional instruments and self-developed novel technique, to measure/determine 
medical parameters using in biomedical studies. These are achieved through three 
projects listed as following: 
1. Designed and fabricated dual-core fiber-optic pH micro-probe used to measure 
pH value in niche environment where cells were treated with TiO2 nanoparticles. 
2. Developed a targeted HPLC-MS/MS method to simultaneously determine four 
urinary biomarkers of renal cell carcinoma and the application in the preliminary 
clinical studies. 
3. Developed a vacuum-based loading system to charge PWHGMs with target 
materials as well as an effective washing procedure, and obtained NMR evidence 
of loaded materials in microspheres and its exchange with surrounding solutions 
as well as the kinetic releasing, which provide valuable information for the 
microspheres used in drug delivery. 
1.9.DISSERTATION ORGANIZATION 
This dissertation is comprised with three parts that individually describe three 
unique analytical techniques to determine three biological parameters. It is organized as 
follows. 
In part one (Paper I), a dual-core fiber-optic pH micro-probe was designed and 
fabricated. The characterizations of the newly developed probe were done with inverted 
fluorescent microscope, scanning electron microscopy, and energy-dispersive X-ray 
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spectroscopy (EDS). The well-characterized pH probe was the applied to measure the pH 
change in the niche environment where cells were treated with different concentrations of 
TiO2 nanoparticles. This study included the development a novel analytical technique and 
its application in nanoparticle toxicity. 
In part two (Paper II), a target HPLC/MS-MS method was successfully developed 
to simultaneously determine quinolinic acid, 4-hydroxybenzoic acid, gentisic acid and α-
ketoglutaric acid as RCC biomarkers in urine. The method was developed in 1% 
synthetic urine. The method was fully validated in real urine specimen with method 
detection limits, spiked recovery accuracy and reproducibility. Finally, the method was 
applied in urine specimens collected from 24 healthy people and 3 kidney cancer  
patients.  
In part three, a vacuum-based loading system was established to load target 
materials into the microspheres. A follow-up washing procedure was developed to 
remove excess amount of materials from the outside of the microspheres. Unloaded and 
loaded microspheres were imaged by inverted optical microscopy. The unloaded 
microspheres were also characterized with field emission scanning electron microscopy 
(FESEM). Two binary systems, C12H26/D2O and CHCl3/D2O, were evaluated to obtain 
NMR evidence that material was loaded into the microspheres. Second, the esterification 
of isopropanol with acetic acid and its hydrolysis reactions were assessed with NMR 
spectroscopy to indicate the exchange of material from the inside of the microspheres 
with the surrounding solution. Microspheres loaded with water (H2O) were submerged 
into D2O to study the microsphere release kinetics. NMR spectroscopy provided time-
dependent data that could be fitted to a double-exponential raise to maximum curve. The 
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fitted curve showed two very specific release rates that may be due to the two specific 
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Biological studies of tissues and cells have enabled numerous discoveries, but 
these studies still bear potential risks of invalidation because of cell heterogeneity. 
Through high-accuracy techniques, recent studies have demonstrated that discrepancies 
do exist between the results from low-number-cell studies and cell-population-based 
results. Thus the urgent need to re-evaluate key principles on limited number of cells has 
been provoked. In this study, a novel designed dual-core fiber-optic pH micro-probe was 
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fabricated and demonstrated for niche environment pH sensing with high spatial 
resolution. An organic-modified silicate (OrMoSils) sol-gel thin layer was functionalized 
by entrapping a pH indicator, 2′, 7′-Bis (2-carbonylethyl)-5(6)-carboxyfluorescein 
(BCECF), on a ~70 μm sized probe tip. Good linear correlation between fluorescence 
ratio of I560 nm/I640 nm and intercellular pH values was obtained within a biological-relevant 
pH range from 6.20 to 7.92 (R
2
 = 0.9834), and with a pH resolution of 0.035 ± 0.005 pH 
units. The probe’s horizontal spatial resolution was demonstrated to be less than 2mm. 
Moreover, the probe was evaluated by measuring the localized extracellular pH changes 
of cultured human lung cancer cells (A549) when exposed to titanium dioxide 
nanoparticles (TiO2 NPs). Results showed that the probe has superior capability for fast, 
local, and continual monitoring of a small cluster of cells, which provides researchers a 
fast and accurate technique to conduct local pH measurements for cell heterogeneity-
related studies. 
Key words: pH micro-probe; Fiber-optic sensor; Cell heterogeneity; Local/niche 
environment sensing; Organic modified silicates (OrMoSils); TiO2 nanoparticles (NPs) 
cytotoxicity. 
1. INTRODUCTION 
Tissue and cellular level biological studies have enabled numerous scientific 
discoveries and biomedical applications. However, potential risks still exist when cell 
heterogeneity is taken into consideration, which may invalidate some of the fundamental 
principles that have been established previously [1-3]. The recent data generated by new 
high-accuracy techniques indicate that discrepancies do exist among those cell-
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population based results [4-7], and thus there is an urgent need to re-evaluate some 
essential parameters with limited number of cells in order to truly realize precise 
medicine in the future. 
The intra-/inter-cellular pH, as one of such key parameters, plays a key role in 
many cell behaviors and responses to surrounding stimuli [8]. The pH in cytosol and 
nucleus is normally adjusted to 7.2–7.4, and to 4.0-5.5 in endosomes and lysosomes [9, 
10], and pH dysregulation leads to dysfunction of cells [11-14]. However, it is interesting 
to note that the intra- and extra-cellular pHs of tumor cells are regulated to be >7.4 and 
around 6.7-7.1, respectively [15-17], which is quite different from normal cells. These 
and more examples [18-21] demonstrate the significant roles that pH plays in many cell 
events. Unfortunately, current available techniques cannot provide the fast and local 
cellular pH measurements with high spatial resolutions that are necessary to distinguish 
potential heterogeneity among different cells. Conventional fluorescent dyes, like 2’,7’-
bis-(2-carboxypropyl)-5-(and-6-)-carboxyfluorescein (BCPCF) [22] and 2′,7′-Bis (2-
carbonylethyl)-5(6)-carboxyfluorescein (BCECF) [17],  are commonly used pH 
indicators, and in most cases they are hydrophobically modified for cytosolic but not for 
extracellular sensing.  Particle-based nano-sensors, a new type of pH sensors, which can 
be embedded with Oregon Green (OG) and fluorescein, have been reported [23-25]. 
However, their potential toxicity of nanostructures to cells is still a problem for real time 
pH measurements while cells are still functioning. Other pH measurement approaches, 
such as fluorescence resonance energy transfer (FRET) based probes [26] and ion-
sensitive field-effect transistor (ISFET) based sensors [27, 28], encounter more or less 
complexity and difficulties in their detecting principles and/or fabricating processes. In 
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addition, dealing with toxic heavy metal elements during probe development and 
manufacturing is also a concern in semiconductor-based approaches.   
Fiber-optic-based sensors have been developed that are easy to fabricate, quick to 
respond, able to provide high spatial resolution detection, and have minimum 
invasiveness to cells [29-32]. A unique way of making fiber-optic-based pH sensors has 
been reported by using sol-gel coating techniques [33]. The novel point in using a sol-gel 
derived thin layer is that its nano- to micro-scale porous structure of the solidified 
networks can effectively entrap the pH indicating molecules. Furthermore, formed 
aerogel has high thermal stability and optical transparency, and is feasible for direct 
coating onto glass substrates [34].  
In this study, a newly designed dual-core double-fiber twisted pH probe for quick 
fabrication and application was successfully fabricated and validated for niche cellular 
environment pH monitoring. The dual-core double-fiber configuration was fabricated by 
using a home-built twisting and gravitational-stretching system. A semi-spherical head 
design was applied in the new probe for maximum fluorescence reflection and collection, 
and the new probe head design was achieved by a distant fusion splicing method. Again, 
the pH sensitive dye BCECF was used and covalently entrapped in an organic-modified 
silicate (OrMoSils) sol-gel thin layer that was coated onto the sensing-head surface. The 
follow up scanning electron microscopic (SEM) imaging and energy-dispersive 
spectroscopy (EDS) characterization showed the successful fabrication of this probe, and 
probe validations in both standard pH buffers and cultured human lung cancer cells that 
were exposed to TiO2 nanoparticles (NPs) were conducted in order to demonstrate the 
probe’s applicability in many potential biomedical research areas.   
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2. MATERIALS AND METHODS  
2.1. Fabrication and Coating of Micro-pH Probe  
The dual-core micro-pH probe with a semi-spherical head shape was fabricated 
from two single mode optical fibers with core and cladding diameters of 62.5 and 125 µm 
(Corning, MA) using a homemade twisting and gravitational-stretching system 
(Figure. 1a). The cores of two optical fibers were fused with an optical fiber fusion 
splicer (Fujikura, Japan). In order to minimize background noise, one of the optical fibers 
served as an excitation laser transmission while the second fiber was used for 
fluorescence light collection. The pH-sensitive fluorescent dye 2′, 7′-Bis (2-
carbonylethyl)-5(6)-carboxyfluorescein (BCECF) (LifeTechnologies Inc., New York) 
was mixed with an ultra-thin aerogel layer for pH sensing. The sol-gel dip-coating 
procedure was similar to our previous study [35, 36]. The chemicals used for coating, 
including dimethyl sulfoxide (DMSO), 2-succinimido-1,1,3,3 tetram-ethyluronium 
tetrafluoroborate (TSTU), N-ethyldiisopropylamine (Hünig’s base), (3-Aminopropyl) 
triethoxysilane (APTES), tetraethoxysilane (TEOS), methyltrimethoxysi-lane (MTES), 
were purchased from Sigma-Aldrich (St. Louis, Missouri). The probe was acidified with 
concentrated nitric acid for 12 hours and washed with sufficient amount of Mili-Q (MQ) 
(EMD Millipore Corp., MA) water and pure ethanol. The probe was then dried at 100 ˚C 
for at least 3 hours. An alkoxides mixture was prepared with APTES, TEOS and MTES 
at a ratio of 4:1:1 (v/v) with catalytic amount (2% of total volume) of hydrochloric acid 
(0.1 M). The dried probe was dipped into the alkoxides mixture with a drawing rate of ~1 
mm/s, and this process was repeated 8 – 10 times to obtain a sufficiently thick layer after 
curing. The mixture of BCECF, TSTU, and Hünig’s base was reacted for one hour at 
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room temperature. The probe was then dipped into the dye solution for about 20 minutes 
and was incubated for 6 hours at 50 ˚C and then another 24 hours at 80 ˚C. 
 
Figure 1. Procedures of fabricating dual-core twisted micro-pH probe. a) Fabrication of 
the probe stem by double-fiber twisting and gravitational-stretching using a home-built 
device; b) SEM and inverted microscopic images of fabricated probe stem and tip; c) 
schemes of how to fuse paralleled tapered fiber tips into the final dual core configuration 
using distant fusion splicing method; d) inverted microscopic image of fabricated dual 
core probe tip under white light; e) fabricated probe tip image under Fluorescein 
isothiocyanate (FITC) channel. 
2.2. Characterization of Micro-pH Probes 
The coated dual-core micro-pH probes were imaged by an inverted fluorescent 
microscope (Olympus IX51, Olympus, center valley, PA, USA) and scanning electron 
microscopy (SEM). The thin layer of coating on the probe’s tip was characterized by 
energy-dispersive X-ray spectroscopy (EDS) (FEI, Hillsboro, OR, USA), including five 
scanned elements, carbon (C), nitrogen (N), oxygen (O), silicon (Si) and gold (Au). An 
inverted fluorescent microscope was used to take images of the probe under white light 
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and an FITC fluorescent channel, with which the BCECF dye can be examined. A quick-
dry epoxy resin (EpoHeat, Buehler, Illinois) was used to embed the finished probes into 
the solidified resin, followed by cross-sectioning and fine grinding to just expose the 
probe head.  
The pH probe was excited by a 488 nm continuous-wave (CW) Argon ion laser 
source (Spectra-Physics Lasers, Mountain View, California, USA), and a USB2000 
spectrometer (Ocean optics, Dunedin, Florida) was used to collect the fluorescent signals 
at 560 nm. Before use, each fabricated probe was calibrated with a series of standard pH 
buffer solutions, which were prepared in 0.1 M phosphate buffer solution (PBS) (Life 
Technology, New York, USA). The pH values of the standard buffer solutions ranged 
from 5.86 to 8.45 with pH intervals around 0.2 that were first calibrated with Accumet 
AB15+ pH meter (Fisher Scientific, Pittsburgh, PA, USA). Afterwards, the coated dual-
core double-fiber-twisted pH probe was dipped into pH solution for 15 ± 5 seconds to 
obtain a stable fluorescence reading, and the fluorescent spectrum was acquired. The 
probe was then rinsed with a sufficient amount of MQ water before the next measurement 
was conducted. 
2.3. TiO2 Nanoparticles and Characterization 
The TiO2 nanoparticles with sizes of 30 – 50 nm were purchased from Sigma-
Aldrich (St. Louis, Missouri). The suspension of TiO2 was prepared in cell culture 
medium without serum and sonicated 15 minutes by an ultrasonicator (FS-60H, 130W, 
20 kHz; Fisher Scientific, Pittsburg, PA, USA). The TiO2 nanoparticles were imaged and 
characterized by transmission electron microscopy (TEM) and EDS. 
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2.4. Spatial Resolution Test of Micro-pH Probe 
TiO2 NPs were measured 3.5 mg in total, and were slowly dosed directly onto one 
single point (diameter < 1mm) at the bottom of a dish that was pre-cultured with A549 
cells. The pH of three different local points in the same dish, at distances from the NP-
dosing spot of 0 mm, 2 mm and 10 mm, were continuously monitored using our probe for 
4 hours. Meanwhile, a separate dish that was also dosed with same amount of TiO2 NPs 
but without cell cultures was also monitored to evaluate pH variation caused by NPs. 
2.5. Cell Culture Conditions and Treatment with TiO2 
The adenocarcinomic human alveolar basal epithelial cell line, A549, was 
obtained from American Type Culture Collection (ATCC) (Manassas, Virginia). Ham’s 
F-12K medium with L-glutamine was purchased from Caisson Laboratories (North 
Logan, Utah), and was supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 
1% non-essential amino acids, 50 U/mL penicillin, and 50 mg/mL streptomycin for sub-
culture. Cells were cultured at 37 °C with 5% CO2 and 95% humidity. A549 cells were 
pre-seeded into a 96-well plate (Corning Inc., New York) at a density of 1 ×10
5
 cells per 
well in 200 µL culture medium and cultured for 16-18 hours to allow cells to attach. 
Different concentrations (50, 100 and 150 µg/mL) of TiO2 NPs suspensions were 
prepared separately with Ham’s F-12K medium and immediately applied to the cells after 
pretreatment. Cells without NPs treatment served as controls in each experiment. The pH 
reactive oxygen species (ROS) generation and cell viability were all measured after 0, 1, 
3, 6, 12, 24, 36, and 48-hour exposures to the nanoparticles. 
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2.6. pH Measurement of Cell Colony 
The coated dual-core micro-pH probes were applied to measure the pH of the 
micro-environment around the cells treated with different concentrations of TiO2 
nanoparticles. After exposure to different concentration of TiO2 nanoparticles for 1, 3, 6, 
12, 24, 36, and 48 hours, the probe was dipped into each well to conduct a pH 
measurement. After each measurement, the probe was rinsed with sufficient amounts of 
MQ water. 
2.7. Assessment of Cytotoxicity 
To determine the cytotoxicity of TiO2 nanoparticles, the cell proliferation reagent 
WST-1 (Roche Life Science, Indianapolis, Indiana) was used following the 
manufacturer’s instructions. After cells were exposed to TiO2 nanoparticles for 1, 3, 6, 
12, 24, 36, and 48 hours, the absorbance at 450 nm was measured using a microplate 
reader (FLOURstar; BMG Labtechnologies, Durham, North Carolina).  
The ROS level was determined by using Penicillin–streptomycin, 2’, 7’ - 
dichlorofluorescin diacetate (DCFH-DA) purchased from Life Technology (Grand Island, 
New York). The stock solution was prepared in dimethyl sulfoxide (DMSO) at a final 
concentration of 10 mM and the 20 µM working solution was prepared by diluting the 
stuck solution 500-fold with Hanks’ Balanced Salt solution (HBSS, Life Technology, 
Grand Island, New York). The supernatant was taken out from each well, and cells were 
incubated with the working solution in a dark environment for 1 hour at 37 ˚C. 
Fluorescence was then determined at 485 nm excitation and 520 nm emission using a 




Experimental data in this study was analyzed by one-way ANOVA followed by a 
Post Hoc test. All experimental results were expressed as the mean value, and standard 
deviation (SD) was derived from triplicate measurements. Two-tail Student’s t-test was 
applied for significance testing. The level of statistical significance was presented as a p-
value of <0.05 (*), <0.01 (**) as well as <0.001 (***). 
3. RESULTS AND DISCUSSIONS 
3.1. Probe Fabrication 
Our prior studies [35, 36] have reported the development of micro-spherical and 
1-in-6 hexagonal fiber-optic pH sensors, which demonstrate a new approach to measure 
pH in a confined niche environment, including at the single-cell level. In the present 
study, the probe structure was redesigned to reduce the difficulty of fabrication and to 
achieve quick sensing performance (Figure 1). A twisted fiber configuration provides 
several advantages over a parallel aligning configuration, such as better robustness and 
structural uniformity, thus enhancing the light transmission. The gravitational-stretching 
system provides controllable forces while pulling twisted fibers down to a micro-sized 
taper (Figure 1b). A home-built double-fiber twisting and gravitational-stretching system 
was used for the main sensing stem fabrication (Figure 1a). Using a pencil flame torch 
enabled us to precisely fabricate a short length (0.5 – 1.2 cm) twisted sensor shaft with 
two fibers fused only at the cladding section. A distant-fusion was applied to mildly bend 
inner cores toward each other with an intermediate thin (<5 µm) layer of cladding (Figure 
1c, 1d). Finally, a sol-gel dip-coating procedure was applied, followed by aging, curing, 
23 
 
and carbon dioxide (CO2) supercritical drying. A covalent bond between pH sensitive dye 
and the aerogel was thus formed (Figure 1e), as described in our previous work [35]. 
The fabricated probe was characterized through SEM/EDS scanning (Figure 2). 
Results showed that the fabricated probe head had a diameter of around 80 µm. A cross-
section image evidently proved a cladding-only fusion as expected (Figure 2, a-d). An 
outside enwrapping layer (3 – 8 µm) (Figure 2d) around the two inner fibers was the dye 
embedded aerogel, featured with typical porous networks (Figure 2e), which allows quick 
interactions between protons (analytes) and BCECF molecules. EDS scanning showed 
the existence of high percentages of carbon (20.81%) and nitrogen (6.29%), while 
considerably low oxygen (67.8%) and silica (4.15%) (Figure 2f), when compared to non-
coated area (Figure 2g, h), indicating  successful amide bonding of BCECF [35]. These 
overall observations demonstrated a successful fabrication of a dual-core micro-pH probe 
featured with a BCECF dye-doped aerogel sensing layer.  
3.2. System Setup and Probe Calibration 
The reflection-mode probing system is composed of two major parts, a laser 
excitation pathway, and a fluorescence signal collection pathway, which are joined 
together at the sensor tip [37]. Briefly, the 488 nm Argon ion laser beam was introduced 
into one fiber through focusing, and the excited fluorescence emission can be picked up 
by the other fiber and transmitted to the detector (Figure 3a). More detailed procedures 
can be found elsewhere. Compared to our previous single fiber configuration [35], this 
design can significantly separate the exciting laser and emission signal light through two-
fiber usage and separated cores, thus this design may provide a higher signal-to-noise 
(S/N) ratio.  
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The finished probe was then calibrated by a set of stepping pH buffers that were 
standardized using a conventional pH meter. A fluorescence peak was observed at around 
550 nm (Figure 3b), and the peak intensity was found to be linearly correlated with the 
pH values. The linear correlation range was observed from pH 6.20 to pH 7.92 with a 
coefficient factor of 0.9834 (Figure 3c). Over this pH range, a typical sigmoidal 
correlation was observed. We thus specifically chose to focus on the linear correlation 
region, which had already covered the most interested biologically relevant range.  
Triplicate measurements were conducted for each probe, and several probes were used to 
come up with a pH detecting resolution of 0.035 ± 0.005 pH units calculated by the 
standard deviation from triplicate measurements, indicating a good reproducibility. 
 
Figure 2. Probe characterization by SEM and EDS analysis. a) SEM image of probe tip; 
b) the epoxy module immobilized several finished probe within it; c) three different 
probe cross-sections; d) SEM image of cross section of the dual-core double-fiber twisted 
pH probe; e) magnified image of square area in (d); f) EDS scanning result of red-circled 
area in (e); g) and h) EDS scanning results of yellow-circled areas in (e). 
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Higher sensitivity and pH resolution can theoretically be further achieved by 
increasing the dye concentration or the laser power. However, this was not recommended 
due to the possibility of self-quenching and photo-bleaching [37].  The current 
methodology may also suffer from varied temperature and ionic strength, as has been 
discussed elsewhere [35, 36]. Nevertheless, no significant interferences to the probe were 
observed due to these two factors, as long as the measuring condition fell within a 
biologically relevant range.  
3.3. Determination of Probing Spatial Resolution 
To validate the detecting spatial resolution of the fabricated probe, we used spot 
dosing (Figure 4d) of 30 – 50 nm TiO2 NPs (Figure 4, a-c) to induce cell deterioration. 
Results showed apparent pH decreases in all cells + NP groups, while no significant 
changes were observed in the NP-only groups. Statistically significant differences 
between cells + NP and control groups began to show after the 90-minute NP dosing. 
After 150 minutes, significant differences between cells + NPs groups also started to 
show (Figure 4e). The latter results particularly indicated a site difference of cell 
responses due to the non-evenly distributed NP concentration. The capability to 
differentiate such small-scale pH values also indicated the high spatial resolution of our 
probe. This ability is essentialfor site-specific measurement in a local area, and especially 
when the pH is variated drastically in that niche environment, such as within a small 




Figure 3. a) Schematic diagram of system setup. The integrated system consisted of a CW 
Argon laser source, a prism, a shutter, a focusing lens, a free-space coupling stage, a 
detector, and a computer. The dual-core double-fiber twisted pH probe was integrated 
into the system and was applied for pH measurements in each well of a 96-well plate; b) 
A fluorescent spectra was plotted based on probe signal intensity range from 510 nm to 
650 nm under a set of standardized pH buffer solution that ranged from pH 6.20 to pH 
7.92. The vertical red and blue dash lines represent the peak (550 nm) wavelength and the 
reference wavelength (640 nm) for final ratio-based pH calculation (I550nm/I640nm); c) 
Linear correlation between buffer pH and fluorescent spectra peak intensity.   
3.4. Detecting Early Onset of Cell Deterioration Induced by TiO2 NPs  
To further demonstrate the probe’s ability to detect actual cellular events, the 
probe was applied to monitor cell response to TiO2 nanoparticles. Engineered 
nanoparticles (ENPs), though used in many fields such as biomedical imaging and 
detecting [38, 39], cancer therapy [40], drug delivery [41], water purification [42], and 
cosmetics [43, 44], bear potential toxic concerns due to their intrinsic nano-scale sizes, 




Figure 4. TiO2 NPs characterization and determination of the probe’s spatial resolution. 
a) TEM image of applied TiO2 NPs, and b) zoom-in image of the NPs squared in a). c) 
EDS scanning result showing chemical composition of the TiO2 NPs. d) Schematic of 
how to test the spatial resolution of the pH micro-probe. E) Four-hour continual pH 
monitoring of cells + NP response at three different spots as shown in d), and compared 
with cell-only and NP-only groups. Statistical significance is interpreted as a p-value of 
<0.05 (*), <0.01 (**) as well as <0.001 (***). Scale bar: a) 200 nm; b) 20 nm.       
The NP-caused cell damages are hard to track and study because they are complicated 
and highly spatiotemporally specified. In the present study, both the probe and two 
conventional methods were used to monitor cell changes in pH, viability, and ROS. An 
adenocarcinomic human alveolar basal epithelial cell line, A549 (CCL-185, ATCC), was 
used and a 40 nm sized TiO2 NPs at concentrations of 50, 100, and 150 µg/mL were 
applied for cell exposure up to 48 hours.  A cell-only group was used as the control in all 
tests. An NP-only group was also tested and no significant pH variations were induced by 
the NPs (data not shown).  
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Results showed decreased pHs and cell viabilities and increased ROS 
accumulation in NP-dosed groups (Figure 5). We interpreted these results as an early 
onset of cell deterioration due to the NP’s toxicity, and the down regulation seemed 
related to this process. In detail, higher NP dosages resulted in lower viability and pH, 
and higher ROS generation. Meanwhile, no significant pH variation in the control group 
was observed. A similar result was shown in a previous study where cell apoptosis was 
correlated with TiO2 NP’s concentration [46]. Additionally, a time effect was also 
observed: the longer the NPs were exposed, the lower the viability and pH, while the 
higher the ROS. Compared with the two conventional methods, the pH measurements 
showed at least equal ability in detecting NP-induced cell deterioration (which 
statistically differed from the control group). However, at the highest NP-dosing 
concentration, our probe can effectively differentiate the signals generated by the NP-
dosed cells from those of the control cells (p < 0.05, “*”) when NPs were just applied, 
which is couple of hours ahead of the statistically meaningful results that were reported 
by the viability and ROS assays.  
The purpose of using two traditional assays, cell viability and ROS generation, 
was to demonstrate the effectiveness of the pH probe. On one hand, cell viability was 
reflected by the enzymatic activity of the mitochondrial level of succinic dehydrogenase, 
which was finally represented by the formazan concentration through a colorimetric 
evaluation [48]. ROS generation, one of the known NP-induced syndromes [45, 46, 49], 
has also been correlated with the mitochondrial inner membrane potential [50]. Thus, 
both viability and ROS assays are related to mitochondrial stability and may serve as 
relatively early-stage signs of cell deterioration before whole cell degradation occurs. On 
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, were also correlated with 
pH regulation. And these ion channels were found on both cell and mitochondrial 
membranes [51]. Our results, thus, showed an important correlation between extracellular 
pH and NP exposure. The detected pH changes featured a locally radical acidification due 
to the NP destruction, and such local changes happened faster than the other two 
population-based assays. Although further mechanistic studies on the pH variation 
triggering points during NP-induced cell degradation and its correlation with 
mitochondria stability are still needed, our developed pH micro-probes may find 
applications in detecting subtle and local cellular changes in a fast and stain-free manner. 
4. CONCLUSIONS 
In this study, we successfully developed and fabricated a novel dual-core micro-
pH probe using a home-built double-fiber twisting and gravitational-stretching system. 
The probe was coated by a specific OrMoSils dye-doping method and applied for pH 
sensing in a microliter environment. The enhanced mechanical structure of the probe with 
fused double fibers successfully separated the excitation beam and emission light, thus 
providing the robust probe with reduced background noise and increased sensitivity. A 
linear correlation between pH and spectral peak intensity was found within a biologically 
meaningful pH range of 6.20 to 7.92 and a coefficient factor of 0.9834 was achieved. The 
probe’s spatial resolution was then exemplarily tested and a resolution of at least 2 mm 
was clearly demonstrated in a cell + NPs exposure test. We finally applied this probe in a 
TiO2 NP-induced cytotoxicity assay. Results revealed a concentration/time dependence of 
the NP’s cytotoxicity. Results also demonstrated the probe’s potential for fast, local and 
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continuous monitoring of cellular events in a staining-free manner, which may greatly 
impact future quasi-single-cell and cell-heterogeneity-driven researches. 
 
Figure 5. The application of the novel pH probe in measuring cell colony’s pH variations 
and their comparison d with cell viability and ROS generation in a TiO2 NP-induced 
cytotoxicity model. Green plots are pH measurement using our developed probe, blue and 
red plots are data are the cell viability and ROS kits measurements. Three NP 
concentration, 50, 100 and 150 µg/mL, were used is this study. Values are mean ± SD (n 
≥ 3). Statistical significance was indicated by *p < 0.05 (significant), and ** p < 0.01 
(very significant), versus the control groups. 
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Renal cell carcinoma (RCC) remains a difficult-to-detect cancer for which new 
detection methodologies are urgently needed to improve screening efficacy. Urinary 
metabolomic profiling has identified several potential RCC biomarkers, including 
quinolinic acid, 4-hydroxybenzoic acid, gentisic acid and α-ketoglutaric acid. These four 
endogenous metabolites have unique pathophysiological mechanisms associated with 





the lack of targeted analytical methods for their simultaneous determination in urine has 
hindered efforts to evaluate their clinical applicability. In this study, a robust high-
performance liquid chromatography - tandem mass spectrometry (HPLC-MS/MS) 
technique using multiple reaction monitoring was developed to simultaneously monitor 
these four urinary biomarkers. The method was validated by multiple figures of merit 
including method detection limits (0.05 ng/mL to 1 ng/mL), spiked recovery accuracy 
(88.6% - 114.8%) and reproducibility (0.4 – 9.3% RSD). The applicability of the method 
was further demonstrated in clinically relevant 100-fold diluted urine specimens. All four 
potential biomarkers were successfully quantified with urinary concentrations that were 
in agreement with previous reports. In conclusion, an accurate and sensitive method has 
been described for the simultaneous determination of quinolinic acid, 4-hydroxybenzoic 
acid, gentisic acid and α-ketoglutaric acid. We anticipate this method to significantly 
benefit clinical translational research aiming to evaluate the clinical applicability of these 
four potential biomarkers. 
Key words: Liquid chromatography – tandem mass spectrometry; Quinolinic 
Acid; Gentisic acid; 4-Hydroxybenzoic acid; renal cell carcinoma 
1. INTRODUCTION 
Renal cell carcinoma (RCC), more colloquially known as kidney cancer, remains 
a difficult-to-detect cancer with 64,000 expected new U.S. cases in 2015, representing 
3.8% of all new expected cancer diagnoses in the United States[1]. While RCC incidence 
has risen in recent years, whether this increase can be attributed to improved screening 





computerized tomography (CT) scans, have proven effective in detecting renal masses in 
symptomatic RCC cases[4, 5]. Recent advances in contrast-enhanced ultrasonography 
(CEUS)[6] and positron emission tomography – computed tomography (PET-CT)[7] 
have further enhanced diagnostic accuracy. However, the high prevalence of 
asymptomatic RCC cases poses considerable diagnostic challenges for medical imaging 
approaches to RCC detection and diagnosis. Namely, routine screening in the general 
population is still not considered cost-effective. Overdetection of small, indolent renal 
masses, representing some 70% of all RCC cases[8, 9],many of which are detected 
incidentally from bladder and prostate cancer screenings[4, 10-12], has substantially 
contributed to increased costs and toxicities associated with overtreatment. Patient 
management and treatment decisions have consequently shifted toward increased active 
surveillance of indolent masses over exclusive use of radical nephrectomy [7]. However, 
active surveillance is not a viable patient management option for socioeconomically 
and/or geographically disadvantaged patients, and for those that it is, can burden patients 
who must undergo follow-up imaging with new costs and morbidity. Finally, these 
technological advances in RCC detection have not meaningfully impacted RCC mortality 
despite greatly increased incidence rates. New molecular-based techniques capable of 
reflecting RCC carcinogenesis and progression are therefore urgently needed to better 
discriminate biologically aggressive tumors from indolent renal masses and improve 
patient outcomes. 
Metabolomics represents an emerging “omics” approach to link 
pathophysiological metabolic changes to individual patient care. Unlike the genome or 





an organism to both internal and external stimuli[13, 14]. Urinary metabolomics is 
rapidly emerging as a patient- and laboratory-friendly diagnostic platform owing to its 
noninvasive detection modality, minimal burden to patients, and inexpensive assays. 
While proteomics has been extensively applied to RCC biomarker discovery, RCC 
metabolomics remains relatively underdeveloped [15, 16]. Nevertheless, recent research 
has identified a growing panel of potential metabolic biomarkers such as hippuric acid 
and myoinositol[17], acetoacetate and lactate[18, 19], and sphingomyelin [20] with 
potentially wide-ranging metabolic implications affecting phospholipid catabolism, 
tryptophan metabolism, phenylalanine metabolism, nicotinate and nicotinamide 
metabolism, citric acid cycle, benzoate metabolism, and more[20, 21]. While analytical 
methods exist for the detection of these compounds in bodily fluids, four 
metabolomically implicated compounds, α-ketoglutaric acid, quinolinic acid, gentisic 
acid, and 4-hydroxybenzoic acid, are particularly promising biomarkers for the detection 
and diagnosis of RCC based on their underlying pathophysiology related to RCC.  
Briefly, quinolinic acid, a NAD
+ 
precursor and an essential intermediate in the 
tryptophan metabolism pathway, is overexpressed in pathological RCC [21-24]. 
Tryptophan metabolism up-regulation is related to increased cellular glycolytic activity 
[25, 26] while increased activity of catalytic enzyme indoleamine 2,3-dixoxygenase has 
further been shown to suppress immune cell proliferation and promote immune escape 
[27-29]. For these reasons, the related tryptophan and kynurenine pathways have been 
used to stage various cancers[30]. α-Ketoglutaric acid is a classic Warburg metabolite 
that is differentially expressed from citric acid cycle up-regulation and activation of the 





hydroxybenzoic acid serve important roles in the benzoate degradation via hydroxylation 
pathway and may function in preventing lipoprotein oxidation in cancer cells [21, 31]. 
This functional understanding has led to considerable clinical interest that aims to 
evaluate the clinical applicability of these four compounds in RCC screening. However, 
no quantitative analytical techniques have yet been described for their simultaneous and 
sensitive detection in urine. While a number of methodologies encompassing an array of 
analytical platforms such as LC-MS [32-34] and GC-MS [35-37] have been reported to 
detect these metabolites individually in various biomatrices, no techniques currently exist 
for urinary screening purposes to the best of our knowledge. Therefore, we sought to 
develop a targeted high-performance liquid chromatography – tandem mass spectrometry 
(HPLC-MS/MS) technique using hybrid quadrupole – linear ion trap (QqLIT) tandem 
mass analyzer to accurately and rapidly determine these four urinary biomarkers.  This 
analytical platform utilized multiple reaction monitoring (MRM) scans, which 
advantageously monitor the structure-dependent transition from unique precursor ions to 
unique product ions following analyte fragmentation by collision gases. This two-step 
approach to analyte quantification greatly minimizes potential isomeric interferences, 
affording highly selective quantification in complex urine matrices that likely have 
multiple isomeric interferences. The applicability of the newly developed method to 
clinical screening efforts was finally demonstrated in clinical urine specimens collected 






2. RESULTS AND DISCUSSION 
2.1. MS/MS Optimization 
The four compounds were individually optimized with respect to compound-dependent 
parameters and ion transitions using direction infusion MS/MS. Direct infusions were 
performed using reagent standards prepared at a concentration of 200 ng/mL in 0.5% 
formic acid to mimic speciation and adduct formation under relevant matrix conditions. 
An automated syringe pump infused standards at a rate of 0.30 mL/hour. Prior to the 
selection of 0.5% formic acid, other additives such as acetate acid, ammonium acetate, 
and ammonium formate were considered but yielded suboptimal ionization efficiencies. 
During the infusion, full scan data acquisition utilizing Multiple Channel Analyzer 
(MCA) modes under positive and negative ionization were initially used to identify 
primary precursor ions and any potential analyte-additive adducts. Briefly, ionization 
efficiencies for the hydroxyl-containing 4-hydroxybenzoic acid and gentisic acid were 
approximately equivalent for negative ion ([M-H]
-
) and positive ion ([M+H]
+
) modes. 
Negative ion mode afforded the most efficient ionization mechanism for dicarboxylic α-





ions. For this reason, negative-ion ESI ionization facilitated by 0.5% formic acid additive 
was selected for mass spectrometric detection of the four compounds. Following 
selection of the precursor ion and ionization method, automated MS/MS parameter 
optimization for each compound provided the following compound-dependent 
parameters: declustering potential (DP), collision energy (CE), and collision cell exit 
potential (CXP) (Table 1). The two highest intensity ion transitions were selected as the 





temperature and gas flow rates, were subsequently optimized with flow injection analysis 
as described in the experimental section. 
2.2. HPLC Optimization 
Chromatographic separation, despite the advantages of using tandem mass 
spectrometry, remains necessary for urinalysis to minimize interferences including those 
that alter ionization efficiencies and those that have similar fragmentation patterns. The 
potential for interferences in heightened in RCC patients who may suffer from impaired 
renal function, leading to clearance of normally-retained physiological biomolecules. For 
example, the Human Metabolome Database lists several naturally occurring metabolites 
with equivalent precursor ions to the selected RCC biomarkers such as cysteine and 4-
hydroxyproline. For this reason, the four analytes were additionally optimized with 
respect to chromatographic separation to provide superior sensitivity and accuracy in 
urine matrices. 
Polar-capped reversed-phase columns were evaluated based on previously developed 
methods for separation of similarly polar metabolites[38-40]. Specifically, a Synergi 
POLAR-RP (4.0 µm, 2.0 × 150 mm, Phenomenex, USA), a Luna phenyl-hexyl (3.0 µm, 
3.0 × 150 mm, Phenomenex, USA), and a Synergi Fusion-RP column (4.0 µm,3.0 × 150 
mm, Phenomenex, USA) were examined for their ability to effective retain and separate 
the selected RCC biomarkers. The Luna phenyl-hexyl column afforded acceptable 
retention of 4-hydroxybenzoic acid and gentisic acid, but failed to retain quinolinic acid 
and α-ketoglutaric acid. The Synergi POLAR-RP column was unable to provide 
sufficient separation and retention for all four analytes. Meanwhile, the Synergi Fusion-






Table 1. Optimized MS/MS parameters for selected RCC biomarkers. 












Quinolinic acid 165.9/121.9 -30 -14 -7 -10 
165.9/78.0 -30 -20 -3 -10 
4-Hydroxybenzoic 
acid 
136.9/93.0 -35 -22 -5 -10 
136.9/65.2 -35 -42 -1 -10 
Gentisic acid 152.9/107.9 -20 -30 -7 -10 
152.9/108.9 -20 -20 -5 -10 
α-Ketoglutaric acid 144.9/101.0 -35 -12 -5 -10 







Figure 1. Extracted-ion chromatograms (XIC) for the quantitation and confirmation 
MRM transitions for each of the candidate RCC biomarkers prepared at 500 ng/mL in 1% 
synthetic urine using the newly developed HPLC-MS/MS method. Separation 
parameters: Column: Synergi Fusion reverse phase (4.0 µm, 3.0 × 150 mm); flow rate: 
0.4 mL/min; injection volume: 50 µL; mobile phase: 0.5% formic acid in ultrapure water 
and 0.5% formic acid in methanol. 
Following column selection, formic acid additive concentrations were optimized 
for chromatographic separation. Lower concentrations (<0.5% v/v) resulted in quinolinic 
acid peak broadening, prompting the selection of 0.5% formic acid in the final 
methodology. A representative chromatogram of a real 100-fold diluted urine sample has 
been shown in Figure 2. The occurrence of system peaks next to analyte peaks in real 
urine samples prompted us to investigate whether these additional peaks may represent 





spiked concentrations was performed to confirm linear responses by the desired analyte 
peaks while the additional, spurious peaks remain unchanged. These results indicated 
these additional peaks had no impact on the accuracy of the newly developed method.  
 
Figure 2. Representative chromatogram of a 100-fold diluted urine specimen. Analyte 
peaks are labeled as follows: 1. α-Ketoglutaric acid; 2. Quinolinic acid; 3. 4-
Hydroxybenzoic acid; 4. Gentisic acid. 
2.3. Method Performance 
The newly developed method was rigorously validated with conventional figures 
of merit including determination of instrumental detection limits, method detection limits, 
limits of quantification, linearity, spiked recovery studies, measures of intra- and inter-
day precision, and application to real urine specimens. Calibration standards were spiked 





standard addition method. The resulting calibration curve was used to determine linearity, 
operating linear range, and detection limits.  The calibration range was set between 0.001 
ng/mL and 1000 ng/mL to encompass anticipated urinary ranges following a 100-fold 
dilution. Limits of quantification (S/N > 10) ranged from 0.05 ng/mL for gentisic acid to 
1 ng/mL for quinolinic acid. Linear ranges were set at the limit of quantification to the 
upper limit of the calibration range (1000 ng/mL) and were found to have excellent 
linearity within these ranges (R
2
 > 0.9997). Linear regression analyses for the calibration 
curves and method performance parameters for each analyte have been summarized in 
Table 2. Spiked recovery studies (n = 3) were performed to determine accuracy and 
precision in biologically relevant sample matrices and anticipated analyte concentrations. 
These experiments indicated the newly developed method was highly accurate (88.6%-
114.8%) and precise (0.4% - 9.3% RSD) as shown in Table 3. Method precision was also 
assessed with intra- and inter-day variations using real urine specimens. These tests 
indicated acceptable intraday variance (1.2% - 2.8% RSD) and interday variance (2.4% - 
5.1%). Together the figures of merit suggest the newly developed technique is 
sufficiently sensitive, selective, and reproducible for analyte quantification in urine 
matrices. 
2.4. Urine Sample Analysis 
Clinical applicability of the newly developed HPLC-MS/MS method was 
demonstrated in urine specimens collected from clinically relevant screening populations. 
This component of the study did not aim to generate or confirm any biological 
hypothesis, but merely aimed to demonstrate the technique was applicable in both healthy 







Table 2. Method performance parameters for the newly developed HPLC-MS/MS technique including linear range and equations, 
standard deviation of slope, standard deviation of the intercept, standard deviation of residues, quantifiaction limits, detection limits, 






































α-Ketoglutaric acid 1.0-1000 y = 1401.9x - 3558.1 13 4966 1554 0.9999 1.0 0.75 2.53 ± 0.05 
Quinolinic acid 2.5-1000 y = 5913.7x - 16852 91 36867 12097 0.9998 2.5 1.0 2.92 ± 0.04 
4-Hydroxybenzoic 
acid 
0.75-1000 y = 2773.6x - 8497.9 51 18648 5580 0.9997 0.75 0.25 6.40 ± 0.03 
Gentisic acid 0.25-1000 y = 11359x - 4475.9 65 21488 5937 0.9999 0.25 0.05 6.45 ± 0.04 
†
These values denote concentrations in undiluted urine.  
††







Table 3. Accuracy and precision of the newly developed HPLC-MS/MS method. All values are presented as a percentage. 




Compounds Recovery RSD Recovery RSD Recovery RSD RSD RSD 
α-Ketoglutaric acid 92.9 6.7 105.6 5.7 100.4 0.4 2.8 5.1 
Quinolinic acid 112.0 4.8 108.4 9.3 114.8 4.5 2.1 4.9 
4-hydroxybenzoic 
acid 
99.9 8.1 94.4 2.2 88.6 6.1 1.8 2.4 





population hindered efforts to accrue a statistically significant number of RCC patients. 
For this reason, a total of 27 urine samples (NRCC = 3; Nhealthy = 24) were analyzed in this 
study. Larger study populations will be necessary to generate meaningful statistical 
conclusions regarding the clinical applicability of these four compounds in RCC 
detection and diagnosis. Importantly, all four compounds were successfully quantified 
(S/N > 10) in 100-fold diluted urine from both RCC patients and healthy individuals, 
indicating the technique can be readily used for quantification of the four analytes 
without additional, potentially interfering, preparative techniques. Specifically, dilution-
corrected mean values for quinolinic acid, 4-hydroxybenzoic acid, gentisic acid, and α-
ketoglutaric acid were 3,440 ng/mL, 1,134 ng/mL, 547 ng/mL, and 24,830 ng/mL, 
respectively. These concentrations are consistent with previously reported urinary levels 
for these compounds[41-43]. However, urinary analytes must be further adjusted to 
reflect urine concentration-dilution resulting from patient hydration status and time since 
last urination. Urinary creatinine has been conventionally used for this purpose, but there 
are serious drawbacks to this approach. Creatinine is correlated with muscle mass and 
consequently age, gender, physical activity, diet, and disease status among other 
factors[44]. In this study, urinary creatinine differed dramatically in the healthy control 
population consisting of young, physically active males compared with the RCC urine 
specimens, which may result in over-normalization in the healthy group. Age- and 
gender-matching can reduce this error but cannot account for physical activity, diet, and 
disease status. For this reason, urine specific gravity, a correlate of total dissolved solids 
in urine, was used as an alternative normalization factor. Urine specific gravity has been 





populations and diseases where creatinine normalization may be inappropriate[45]. 
Notably, the urine specific gravity levels measured in this study (mean: 1.017; range: 
1.003 - 1.033) matched general population statistics for urine specific gravity, suggesting 
creatinine-based normalization of these four analytes may result in inaccurate 
determinations due to differences in patient muscle mass and physical activity. The serum 
protein, cystatin C, has also been proposed as a highly effective urinary biomarker 
normalization factor in damaged kidneys, although it was not evaluated in this study due 
to a lack of corresponding serum samples[46]. The USG-adjusted mean values for 
quinolinic acid, 4-hydroxybenzoic acid, gentisic acid, and α-ketoglutaric acid were 4,060 
ng/mL, 1,338 ng/mL, 645 ng/mL, and 29,300 ng/mL, respectively, which remained 
consistent with previous reports. Briefly, group comparisons were made using two-tailed 
2-sample Student’s t-Test and the USG-normalized data, although the sample size 
effectively limits any conclusions rendered here. In this limited study, compounds were 
found to be higher in RCC, including α-ketoglutaric acid (µRCC = 35,231 ng/mL, µhealthy = 
29,300 ng/mL, P-value = 0.336), quinolinic acid (µRCC = 5,960 ng/mL, µhealthy = 4,060 
ng/mL, P-value = 0.140), 4-hydroxybenzoic acid (µRCC = 3,126 ng/mL, µhealthy = 1,338 
ng/mL, P-value = 0.185), and gentisic acid (µRCC = 1,457 ng/mL, µhealthy = 645 ng/mL, P-
value = 0.271).  However, further validation using statistically appropriate sample sizes 







Standard reagents quinolinic acid, 4-hydroxybenzoic acid, gentisic acid, and α-
ketoglutaric acid as well as mobile phase additives ammonium formate (LC-MS grade), 
ammonium acetate (LC-MS grade), acetic acid (LC-MS grade) and formic acid (MS 
grade) were purchased from Sigma-Aldrich (St Louis, MO, USA). Acetonitrile (LC-MS 
grade) and methanol (MS grade) were obtained from Fischer Scientific (Pittsburgh, PA, 
USA). Ultrapure water was obtained using a Milli-Q Advantage A10 and Millipore Elix
®
 
water purification system (Millipore, MA, USA). 
3.2. Standard Preparation 
Dry chemical standards were stored at -20 °C from which stock solutions of 1000 
µg/mL were prepared with ultrapure water. Individual stock solutions were stored at 4 °C 
for no more than three months under dark conditions. Working stock solutions were 
freshly prepared from serial dilution with ultrapure water. Calibration standards ranging 
from 0.001 ng/mL to 1,000 ng/mL were prepared in a 100-fold diluted pooled urine 
sample. 
3.3. HPLC-MS/MS Instrumentation 
A Synergi Fusion reversed-phase column (4.0 µm, 3.0 × 150 mm, Phenomenex, 
USA) and a Shimadzu UFLC system (Columbia, MD) consisting of a vacuum degasser 
(DGU-30A3), two pumps (LC-20 AD XR), an auto sampler (SIL-20AC XR), and a 





0.4 mL/min at 25 °C using a 50 µL injection volume. Compound separation was 
enhanced by using a binary gradient system comprised of A: 0.5% formic acid in 
ultrapure water and B: 0.5% formic acid in methanol. The gradient program was 
initialized at 5% B for two minutes followed by a linear increase of B to 40% over two 
minutes. The 40% B composition was held for one minute followed by a linear increase 
to 80% B in two minutes where it was held for an additional one minute. The B 
composition was dropped to 5% in one minute and held for six and half minutes. The 
total run-to-run time was 16 minutes. 
A 4000 QTRAP mass spectrometer (AB SCIEX, Foster City, CA) was used to 
quantitate the selected RCC biomarkers. The mass spectrometer was operated in 
multiple-reaction mode (MRM) under negative-ion ESI conditions. Nitrogen was used as 
the curtain and cone gases. Optimized ESI parameters included: curtain gas: 35 psi; ion 
spray voltage: -4500V; GS1: 35 psi; GS2: 50 psi; temperature: 450˚C. The MS/MS 
collision gas was set at 6 psi. 
3.4. Method Validation 
Urine represents a biologically complex matrix that presents significant 
bioanalytical challenges. Therefore, the newly developed method was validated through 
several figures of merit including: instrumental limit of detection, method detection limit, 
linearity, intra- and inter-day variance estimation, and performance in spiked recovery 






3.5. Urine Analysis 
Urine samples (N = 27) were collected and subsequently analyzed by the newly 
developed technique to demonstrate clinical applicability. Pathological RCC specimens 
(N = 3) were provided by the Central Missouri Urology Clinic (Rolla, MO) and healthy 
urine specimens (N = 24) were collected from consenting Missouri University of Science 
and Technology undergraduate and graduate students. Additional collection of RCC 
specimens was hindered by the relative rarity of RCC in the local rural population. All 
study participants provided written consent, and the collection was approved by the 
Institutional Review Board at Missouri University of Science and Technology. 
Pathologic specimens originated from three males aged 49, 67, and 85 years-old with 
staged RCC. These individuals had no confounding morbidities and had not received 
prior treatment to their new diagnoses. Twenty-four control samples were additionally 
sampled from healthy individuals ranging from 21 to 59 years of age with no history of 
malignancy and no current illnesses. Urine specimens were collected on-site and 
immediately stored in a -80 ˚C ultralow freezer for approximately one to six weeks prior 
to analysis. Upon complete thawing to room temperature, a 1 mL aliquot was centrifuged 
at 3000 g-force for 20 minutes at 4 °C. The supernatant was additionally filtered with a 
0.22 µm nylon membrane filter to remove any proteins or cells from the urine. Filtered 
samples were diluted to a final dilution factor of 100 with ultrapure water for analysis. 
4. CONCLUSION 
A targeted, quantitative HPLC-MS/MS method was developed for simultaneous 





acid in urine, which has not been previously reported to the best of our knowledge. The 
newly developed method was validated by multiple conventional figures of merit 
including method detection limits (0.05 ng/mL to 1 ng/mL), spiked recovery studies that 
indicated high accuracy (88.6% - 114.8%) and reproducibility (0.4 – 9.3% RSD), and 
acceptable intraday variance (1.2% - 2.8% RSD) and interday variance (2.4% - 5.1%) 
The applicability of the newly developed method was further demonstrated in 27 urine 
specimens from healthy individuals in addition to several RCC patients. All four 
compounds were successfully quantified in urine samples at concentrations were in 
agreement with previous findings. Together these findings suggest the new method can 
be considered sensitive, selective, and highly accurate, enabling researchers to evaluate 
the clinical applicability of these four urinary markers for earlier RCC detection and 
diagnosis. Although higher concentration levels in RCC samples were observed in our 
small sample set, larger study populations will be required to generate statistically 
significant conclusions regarding the clinical applicability of these four compounds. We 
therefore anticipate this method to significantly benefit clinical researchers aiming to 
perform epidemiological studies for these four compounds and to elucidate their roles in 
disease. 
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2. MATERIALS AND METHODS 
2.1. POROUS WALL HOLLOW GLASS MICROSPHERES 
The porous wall hollow glass microspheres (PWHGMs) used in this study were 
provided by MoSci Corporation (Rolla, MO). They consist of a spherical 1-µm thick 
silicate glass shells that enclose spherical central hollow cavities with a diameter that 
ranges from 20 µm to 75 µm. The 1-µm thick shells are penetrated by pores with tortuous 
channels that can range from 10 to 300 nm in diameter. The microspheres, their surface, 
and their pore sizes were characterized by field emission scanning electron microscopy 
(FESEM) (Hitachi 4700, Tokyo, Japan). Figure 2.1 shows electron micrographs of 
PWHGMs, their spherical hollow cavities, and the differently sized pores in the walls. 
The FESEM images confirm that the PWHGMs are indeed spherical with a smooth outer 
surface (Figure 2.1a). In some cases, there are pieces of broken microspheres attached to 
the surfaces of the intact microspheres. The diameters of the microspheres range from 
20 µm to 70 µm. A broken microsphere shell was also imaged by FESEM to show the 
central hollow cavity (Figure 2.1b). Higher magnification of a microsphere shell showed 
many indentations on the surface, which are identified with the pores through the outer 
walls (Figure 2.1c & Figure 2.1d). The pores are only visible as indentations because 
gold sputtering, which was used to prepare the microspheres for FESEM imaging, closed 
the pores. There are two distinct size ranges of the pores: (a) a small number of relatively 
large pores as shown in Figure 2.1d with a diameter between 50 nm and 75 nm, and (b) a 




difference between the large and small pores sizes and the lack of a continuous 
distribution of pore sizes has a major effect on the release of material from the 
microspheres as shown later in the kinetic study presented in this dissertation. Overall, 
the pores and the spherical hollow cavity are characteristic for PWHGMs, making them 
distinguishable from other glass microspheres. 
 
Figure 2.1. SEM images of microspheres. (a): the surface of microspheres; (b): the central 
hollow cavity; (c) and (d): the pores on the wall. 
2.2. NMR INSTRUMENTATION AND SPECTRA ACQUISITION, 
PROCESSING, AND PEAK ASSIGNMENTS 
All 
1
H-NMR spectra presented in this dissertation were obtained using a 5-mm 
broadband probe with z-gradient in the departmental 400 MHz Bruker AVANCE III HD 
NMR Spectrometer. The data were acquired with the following acquisition parameters:  




 spectral width: 4800 Hz  
 number of data points: 32 k 
 pulse width: 14.3 µs  
 recovery delay between scans: 2 s  
 number of scans: 16  
After acquisition, the 
1
H-NMR spectra were phase- and baseline-corrected with 
automated routines of the spectrometer’s TOPSPIN® 3.1 software. In some cases, manual 
refinement of the phase and baseline corrections was necessary to obtain optimized 
spectra. The peak assignments are listed in the Table 2.1 below. 
Table 2.1. 
1








H2O 4.63 CHCl3 emulsion in D2O 7.20
HOD 4.63 CH3COOH 1.84












There are two sets of peaks for C12H26 in D2O as well as for CHCl3 in D2O. The 
reason is that C12H26 has a very low solubility in water (3.7 × 10
-9
 g/mL at 25 °C [110]), 
and so does CHCl3 (8.1 × 10
-3
 g/mL at 25 °C [111]). Hence, C12H26 or CHCl3 in excess of 
the low solubility will form emulsified (i.e., colloidal) particles in solution. The formation 
of emulsified colloids in the mixture of CHCl3 in D2O will be used as the example to 
explain the two NMR peaks (Table 2.1). An emulsion is an unstable system that consists 
of at least two immiscible liquid phases (Figure 2.2). When very small amounts of CHCl3 
are mixed with D2O (< 5 µL in 750 µL D2O) a real solution without emulsified CHCl3 
will form. After saturation of D2O with CHCl3, however, further CHCl3 will form 
emulsified colloids as shown schematically in Figure 2.3. Because of the different 
chemical environment of molecularly dissolved CHCl3 and emulsified CHCl3, two 
signals of different chemical shift are expected, and observed, in the NMR spectra, i.e., 
one for the molecularly dissolved and one for the emulsified species. 
 
Figure 2.2. Illustration of emulsion. Emulsions have different stability characteristics and 
there are applications that demand varying levels of emulsification stability. From left to 
right: a stable emulsion; the emulsion has begun to separate; further separation; the 





Figure 2.3. Dissolved CHCl3 in D2O and emulsified CHCl3 in D2O. 
2.3. DEVELOPMENT OF LOADING SYSTEM 
The vacuum-based loading system is considered novel at this point because it is 
the first time loading PWHGMs with target materials through a vacuum-based system is 
reported. The newly developed procedure (Figure 2.4) for loading PWHGMs with liquid 
materials or materials dissolved in liquids is described in detail below: 
1. A desired amount of glass microspheres is put into a glass vial. 
2. The glass vial is connected to a standard laboratory vacuum pump with the flexible 
rubber hose that tightly fits over the vial. It is ensured that the rubber hose provides 
an air-tight seal with the vial. 
3. The vacuum pump is turned on for about 1 hour to remove all air from the vial and 
with it from inside the hollow microspheres. The airflow must be controlled to be 
reasonably low in order to prevent microspheres from being floated out of the glass 




can escape from the microspheres without generating excessive pressure differences 
between the hollow cavity inside the microspheres and the surrounding atmosphere. 
The delicate microspheres tend to burst if air is removed too fast from the vial and the 
pressure difference becomes too large. 
4. The material intended to be loaded into the hollow spheres is slowly injected through 
the rubber hose (or a separate septum) into the evacuated glass vial with a syringe. 
Depending on the volatility of the charging material, the vacuum pump can be left 
running (low-volatility materials) or must be turned off and separated from the vial 
system by a valve (high-volatility materials). It is advisable to inject as much material 
as is needed to completely submerge the microspheres with liquid. 
5. The microspheres are left in the vial for 12-15 hours (e.g., overnight) to fully allow 
the inside of the microsphere cavities to equilibrate with the surrounding solution.  
 
Figure 2.4. Schematic diagram of loading system. The integrated system consisted of a 
vacuum pump, a glass vial, rubber tube, and a syringe. The PWHGMs was included in 
the system 
Pictures were taken with a digital camera before and after the PWHGMs were 
loaded with H2O (Figure 2.5a & Figure 2.5b). As shown in the pictures, unloaded 




water-loaded microspheres sink to the bottom. Even though the SiO2 of the glass 
microspheres, which is the main component of the microspheres’ shells, has a higher 
density (2.2 g/cm
3
 [113]) than most common liquids (e.g. H2O: 0.9950 g/cm
3
 [114]), the 





keeps the average density of unloaded microspheres below the density of most common 
liquid materials. Therefore, unloaded microspheres will float, for example, on top of 
water. On the contrary, microspheres charged with a liquid material will sink to the 
bottom (Figure 2.5b) due to a higher average density even if the liquid inside the 
microspheres has a considerably lower density that the surrounding fluid. Unloaded and 
loaded microspheres were imaged with inverted optical microscopy as shown in Figure 
2.5c & Figure 2.5d. Because the refractive index is significantly different between air and 
liquid, the image of the unloaded microspheres looks very different from the one of the 
loaded microspheres. What appears to be a thick wall of the microspheres in Figure 2.5c 
is actually the result of the difference in refractive index between liquid (H2O in this 
case) and air. The spherical contours of the microspheres are clearly visible under the 
microscope even after the microspheres were filled with liquid. It shows that the loaded 
microspheres kept their integral structure, which indicates that the exerted pressure 
differences during the loading process did not break the microspheres. There are no air 
bubbles visible inside or outside the microspheres after loading them with liquid 
materials, which shows that a carefully executed vacuum-based loading system is a 
procedure that can be successfully applied to fill microspheres with target materials. To 
fill microspheres with solid components, the same procedure is applied with aqueous or 





Figure 2.5. Images of microspheres before and after loading with H2O. (a) unloaded 
microspheres floated in H2O; (b) loaded microspheres sink down in H2O; (c) inverted 
microscopic image of unloaded microspheres under white light; (d) inverted microscopic 
image of loaded microspheres under white light. The scale bar is 50 µm. 
2.4. WASHING MICROSPHERES THROUGH CENTRIFUGATION PROCESS 
To find NMR evidence of loaded materials inside of microspheres, any excess 
amount of target material must be removed from the surface of the microspheres. The 
target materials that reside outside of the microspheres will result in NMR signals of 
similar, if not the same chemical shift as the materials loaded inside. Therefore, a 
sufficient washing procedure removing all excess material including material attached to 
the outside of the microsphere shells must be applied before analysis. The proposed 




the microspheres. Because either n-dodecane or chloroform was loaded into the 
microspheres, D2O was chosen to wash the microspheres. The microspheres were washed 
with 1 mL portions of D2O followed by centrifugation of the solution. The supernatants 
collected after each washing were individually examined by NMR spectroscopy. The 
washing procedure was generally repeated 3 times, whereupon the microspheres were 
transferred into a 5 mm NMR tube filled with lock solvent (D2O in this example). 
The washing effectiveness was evaluated first with the system CHCl3 and D2O. 
After microspheres were loaded with CHCl3 through the loading procedures described in 
Section 2.3, they were transferred into a centrifuge tube (Eppendorf, NY). D2O was 
added and centrifugation executed. The supernatant was decanted from the centrifuge 
tube and transferred into an NMR tube for recording an NMR spectrum. Figure 2.6 shows 
the NMR spectra of the supernatants before and after three times washing with D2O. 
The spectra show that two peaks can be observed at 7.55 ppm and 7.20 ppm 
before the washing procedure, which are assigned to molecularly dissolved CHCl3 and 
the colloidal CHCl3 emulsion. The peak at 7.20 ppm indicates that there is CHCl3 in 
excess of the dissolution limit of the molecular form present in the supernatant. After the 
third wash, however, no peak is observed at 7.20 ppm, which indicates that all of the 
colloidal CHCl3 emulsion was removed and that only a small quantity of molecularly 
dissolved CHCl3 remained in D2O. These quantities could not completely be removed but 
may originate from material that leaks out of the microspheres during the final washing 
steps. The comparison of supernatants collected at different stages during the washing 




are virtually immiscible with the loaded material is effective to remove excess amount of 




H NMR spectra of supernatants collected during washing process. a) NMR 
spectrum of supernatant collected after three washes. b) NMR spectra of supernatants 
collected before washing. From the left to right peaks are assigned to dissolved CHCl3, 




3. MODEL SYSTEM STUDIES 
The development of new drugs and diagnostic biomarkers is expensive and time 
consuming. But it is not only the drug or biomarker formulation itself but also the way a 
drug or diagnostic biomarker is delivered that scientists have been looking into. Modern 
drug delivery systems are engineered strategies that can deliver drugs and biomarkers to 
target sites and release them in a controlled manner for therapeutic treatments or 
diagnostic applications, respectively. The major goal is to offer targeted delivery only to 
where the medication or diagnostic biomarker is needed, while leaving other sites 
unaffected. Targeted delivery minimizes the amount of drug or biomarker needed for the 
application and also reduces potentially toxic side effects. Specially designed drug and 
biomarker carriers are desired to administer the drugs very selectively. When designing a 
new drug delivery carrier, scientists are faced with questions of biocompatibility, 
quantification of the loaded drugs, and the release kinetics of the drugs from the carriers. 
The model systems studied in this work are designed to provide insights into the release 
mechanisms and kinetics of materials from the inner cavity of PWHGMs to the 
surrounding areas. These studies are the first of its kind and are necessary to understand 
the properties of PWHGMs before they can be put into practice as actual drug delivery 
carrier. In particular, three model systems are used to evaluate the potential of PWHGMs 




3.1. THE MOTIVATION OF THE INVESTIGATION INTO THE BINARY 
IMMISCIBLE SYSTEMS 
Compounds used as drugs or biomarkers are most commonly organic compounds 
that can be divided into two categories, small organic molecules, and biologics (i.e. 
biological medical products). Many properties have to be taken into consideration during 
the development of new drugs or biomarkers, including structural properties (e.g. 
hydrogen bonding, polarity, functional groups, etc.), physicochemical properties (e.g. 
solubility, diffusivity, etc.), biochemical properties (e.g. metabolism, biodegradability 
etc.), as well as pharmacokinetics (PK) and toxicity (half-life, LD50) [116]. However, 
drugs encounter many barriers in living system till they reach the therapeutic target. 
When a drug molecule passes through a barrier, the amount of drug molecules will most 
likely be reduced at the other side of barriers (Figure 3.1) [117]. Unfortunately, there are 
many barriers in a human body including membranes, adverse pH value, metabolic 
enzymes, and molecular transport vehicles or enzymes [118]. For example, orally 
administered drugs are first ingested via the esophagus arriving in the stomach where the 
pH ranges between 1.5 to 3.5 [119]. However, many drug molecules, especially biologics 
such as proteins will break down or decompose at such low pH and thus lose their 
functionalities. The solubility of drug molecules is another crucial factor in drug delivery. 
The drug’s high or low solubility in aqueous or organic solvents determines how it will 
be absorbed by the body and how it may reach its designated area. Therefore, targeted 
drug or biomarker delivery techniques which utilize vehicles that can penetrate barriers 
more easily or even eliminate them have gained much attention in the development of 
drug carriers, particularly if they have the potential to protect drugs from decomposition 




The model systems in this study use microspheres as carriers and C12H26 (n-
dodecane) and CHCl3 (chloroform) as loaded materials. C12H26 was chosen because it is 
an organic molecule with a very low solubility in water. Because the loaded materials 
were characterized with NMR spectroscopy, the straight and simple structure of C12H26 
avoids the generation of too many signals in the 
1
H NMR spectrum, which would make it 
more difficult to unambiguously assign all signals in the spectrum. CHCl3 is a simpler 
chemical with only one type of 
1
H nucleus (proton), which makes it easy to interpret 
NMR spectra quantitatively. The glass microspheres used as carrier and container of the 
chemicals are resistant to acidic solutions, which renders them particularly useful as drug 
carriers for acid-sensitive molecules. 
 
Figure 3.1. The number of active drug molecules is reduced during the passing of a 
barrier. Adapted in modified form from ref [117]. 
3.2. BINARY IMMISCIBLE SYSTEM OF CHCl3 AND D2O 
The CHCl3 and D2O system was studied first as a simple example of obtaining 
insights of binary immiscible system with NMR spectroscopy. CHCl3 only provides one 




3.2.1. Experiments Design and Procedures. The control experiments of the two 
immiscible liquids CHCl3 and D2O were first carried out by adding different amounts of 
CHCl3 (1 µL, 3 µL, 5 µL, 15 µL, and 20 µL) to 750 µL D2O without the microspheres 
present. NMR spectra were recorded for every mixture. Thereafter, microspheres were 
loaded with CHCl3 according to the vacuum-based loading system explained in section 
2.3 and washed three times with D2O following the washing procedures mentioned in 
section 2.4. The final solution was transferred into a 5 mm NMR tube with the sample 
gently shaken before analysis to ensure that the microspheres were homogeneously 
distributed in the NMR active volume. NMR spectra of the microspheres loaded with 
CHCl3 and suspended in D2O were recorded, and integrated signal intensities of the 
CHCl3 peak was used for evaluation. 
3.2.2. Results and Discussion. An important aspect for drug delivery with hollow 
glass microspheres is to know what compounds are loaded into the PWHGMs as well as 
the absolute amount and the concentrations of the loaded compounds. Therefore, an 
analytical technique like NMR is desired, which can determine and quantify loaded 
materials inside the PWHGMs. The series of control experiments was conducted to 
understand the binary immiscible system of CHCl3 in D2O. A narrow singlet peak is 
observed at 7.55 ppm when only 3 µL of CHCl3 is added to the 750 µL of D2O (Figure 
3.2). The solubility of CHCl3 in water at 25 °C is 8.1 × 10
-3
 g/mL [111], and it was 
calculated by the density of CHCl3 (1.49 g/mL at 25 °C) that there was a molality of only 
5.96 × 10
-3
 g CHCl3 per mL D2O when 3 µL of CHCl3 was added to the 750 µL D2O. 
Therefore, the 3 µL CHCl3 was dissolved molecularly in D2O, resulting in the narrow 




the integral of the HOD peak at 4.63 ppm. As more CHCl3 was added, the integral of the 
peak for the molecularly dissolved singlet CHCl3 increased. The maximum solubility for 
CHCl3 in 750 µL D2O was reached by adding 4.10 µL CHCl3. Therefore, the peak for the 
molecularly dissolved CHCl3 reached saturation with an integral of 0.1568 when 5 µL of 
CHCl3 was added to 750 µL of D2O. Meanwhile, as more CHCl3 was added (for 
example, 20 µL CHCl3) to D2O, a new broader peak appeared at 7.20 ppm (Figure 3.3). 
This peak is assigned to CHCl3 mixed with D2O as an emulsion. Every NMR-detected 
nucleus in a molecule has a specific chemical shift value, which depends on its chemical 
environment. Whether molecularly dissolved or emulsified, CHCl3 has the same 
molecular structure, but their chemical environment is different, resulting in two peaks at 
different chemical shifts. While the narrow peak at 7.55 ppm results from CHCl3 in a 
chemical environment of D2O, the chemical shift of the emulsified CHCl3 is closer to the 
chemical shift of pure CHCl3. Accordingly, the chemical environment in the emulsion 
colloids is based more on CHCl3 surrounded by other CHCl3 molecules rather than by 
D2O. The slight difference in chemical shift that the broader CHCl3 peak in D2O exhibits 
compared to a pure CHCl3 NMR sample is attributed to the fact that the emulsion 
colloids are still surrounded by a different chemical environment, i.e., the solvent D2O. 
The integral of the peak for the molecularly dissolved CHCl3 was found to be 0.1568 ± 
0.001 at the point when the emulsion peak first appeared. The peak for the molecularly 
dissolved CHCl3 remained constant when more CHCl3 was added to the CHCl3/D2O 
mixture, which indicates CHCl3 is completely dissolved molecularly until the saturation 
limit is reached, and that an emulsion only appears after the saturation with molecular 




contributing to the signal, which is why NMR spectroscopy is intrinsically quantitative. 
However, integrated signal intensities only give information about the relative number of 
different protons. Consistent with this statement, the ratio of the HOD peak to the 





H NMR spectrum of 3 µL in D2O. The integration of dissolved CHCl3 at 
7.55 ppm was 0.1318 when the HOD peak at 4.63 ppm was set to 1.000. 
The PWHGMs were filled with CHCl3 according to the vacuum-based loading 
procedure (Section 2.3) and washed with D2O (Section 2.4). The washing process was 
necessary to remove excess amounts of CHCl3 on the surfaces of the PWHGMs so that 
NMR spectra provide reasonable evidence of CHCl3 inside of microspheres. After the 
loading and washing process, the CHCl3-loaded PWHGMs were suspended in D2O, and 
NMR spectra were recorded (Figure 3.4). A broad peak is observed at 7.20 ppm and 




same chemical shift as the formerly recorded emulsified CHCl3, indicating that they have 




H NMR spectrum of 20 µL chloroform in D2O. The chemical shifts 
assignments are molecularly dissolved CHCl3: 7.55 ppm, emulsified CHCl3: 7.20 ppm, 
and HOD: 4.63 ppm. 
the microspheres can be seen as providing a template for large colloids or droplets of 
CHCl3, however not as a simple emulsion but surrounded by the glass shell of the 
microspheres. While the CHCl3 in the microspheres exhibits the same chemical shift as 
observed for emulsified CHCl3 (Figure 3.5), the integrated intensity of the narrow singlet 
peak at 7.55 ppm was found to be only 0.1149, which is lower than that expected for the 
peak intensity of the molecularly dissolved CHCl3 in saturation (integral of 0.1568). 
Accordingly, the broad peak at 7.20 ppm (integral of 0.2174) cannot be from emulsified 
CHCl3 in D2O but is attributed to CHCl3 inside the PWHGMs. Additional evidence for 
this statement is provided by the spectrum of the supernatant, which after three times 
washing with D2O did not show any peak for emulsified CHCl3 but only a small peak for 




3.2.3. Conclusions. In this model system, the behavior of CHCl3 in D2O and in 
the cavities of hollow glass microspheres was evaluated. A model study of the binary 
immiscible system of CHCl3 in D2O provided information with respect to two aspects 
(qualitative and quantitative information): (a) molecularly dissolved CHCl3 has a 
different chemical environment than emulsified CHCl3 and, thus, a different chemical 
shift is observed; (b) CHCl3 first dissolves molecularly while emulsion colloids only form 
after saturation is reached for the molecular dissolution. The integrated signal intensities 
for the peak of the molecularly dissolved CHCl3 correlate well with the known molecular 
dissolution limit for CHCl3 in D2O. The results demonstrated that NMR spectroscopy not 
only can provide structural information of the materials loaded in the microspheres, but is 




H NMR spectrum of CHCl3 inside of the microspheres suspended in D2O. 
The peaks from left to right are assigned to dissolved CHCl3 in D2O (7.55 ppm), CHCl3 





Figure 3.5. Comparisons between 
1
H NMR spectra of (a) CHCl3 emulsion peak in D2O 
and (b) peak of CHCl3 in microspheres. Peak A is assigned to the dissolved CHCl3 in 
D2O. Peak B is assigned to the CHCl3 emulsion in spectrum (a) and the CHCl3 in the 
microspheres in spectrum (b).  
3.3. BINARY IMMISCIBLE SYSTEM OF C12H26 AND D2O 
The binary immiscible system of C12H26 and D2O was conducted to simulate the 
real application of the microspheres as drug carriers. C12H26 is a water-non-soluble 
molecule, which is similar to some drugs. 
3.3.1. Experiments Design and Procedures. The control experiments of two 
immiscible solvents were first carried out by adding a series of well-defined amounts of 
C12H26 (1 µL, 2 µL, 3 µL, 4 µL, 5 µL, 6 µL, 8 µL, 10 µL, 20 µL, 30 µL, 40 µL, 50 µL, 
70 µL) to 750 µL D2O without microspheres present. A 
1
H-NMR spectrum was recorded 




according to the vacuum-based loading system of section 2.3 and washed three times 
with D2O following the washing procedures of section 2.4. The microspheres were then 
re-suspended in D2O and the sample gently shaken before the analysis to ensure the 
microspheres were homogeneously distributed in the NMR active volume. An NMR 
spectrum of the suspended microspheres and their loaded material was recorded. The 
detailed experimental procedures were described in Section 2 (MATERIALS AND 
METHODS). 
3.3.2. Results and Discussion. Before the analysis of C12H26 loaded into 
microspheres, control experiments were conducted to obtain general insights into the 
behavior of the virtually immiscible C12H26 in D2O system as observed by NMR. Figure 
3.6 shows NMR spectra of 1 µL C12H26 in 750 µL D2O (Figure 3.6a) and 70 µL C12H26 in 
750 µL D2O (Figure 3.6b). When 1 µL C12H26 was added to 750 µL D2O, there were 
three sets of peaks observed in the spectrum. The singlet HOD peak at 4.63 ppm was 
from 
1
H impurities in the lock solvent D2O, which has a purity of 99.8% with 0.2% H2O. 
The fast exchange between protons from H2O to D2O and vice versa leads to a statistical 
distribution of 
1
H among the water molecules resulting almost exclusively in HOD 
molecules (and almost no H2O molecules) within the solution. The complex, 
asymmetrical peak pattern at 1.17 ppm is assigned to the CH2 groups of C12H26 while the 
low-resolved triplet peak at 0.76 ppm is assigned to the CH3 groups of C12H26. The triplet 
peak is caused by spin-spin coupling (J coupling) to the two protons of the CH2 groups. 
The more complex, asymmetrical CH2 signal cannot be interpreted as a singlet peak at 
1.17 ppm but rather contains several multiplets from couplings between the CH2 groups 




1 µL C12H26 was added to 750 µL D2O, the mass concentration of C12H26 in D2O was 
1 × 10
-3
 g/mL, which is much greater than the reported molecular solubility of C12H26 in 
water (3.7 × 10
-9
 g/mL at 25 °C [110]). Assuming that the solubilities in H2O and D2O 
are similar, the amount of molecularly dissolved C12H26 is below the detection limit of 
NMR spectroscopy (1.8 × 10
-4
 mol/L) and only emulsified colloids of C12H26 contribute 
to the broadened peaks observed in the spectrum. This phenomenon became more 
pronounced when more C12H26 was added into the D2O (e.g., 70 µL in 750 µL D2O) as 
shown in Figure 3.6b. There are four NMR signals present in addition to the HOD/H2O 
peak at 4.63 ppm. The broad peaks next to the peaks assigned earlier to the CH2 and CH3 
groups of C12H26 originate from the separate phase of C12H26 and its CH2 and CH3 
groups. The phase separation of C12H26 in D2O changes the chemical environment of the 
C12H26 molecules and with it the chemical shifts in the NMR spectra. The control 
experiments provide many pieces of valuable information on this binary immiscible 
system that are used here for a model study. First, emulsified C12H26 was easily formed 
due to the low solubility of C12H26 in water, and the peaks from the emulsified C12H26 can 
easily be distinguished from the peaks of phase-separate C12H26. Second, the substantial 
broadening of the peaks is caused by a distribution of the colloidal drop sizes of the 
C12H26 emulsion. Every colloid size creates an NMR signal that has a slightly different 
chemical shift. Overall, the control experiments offer sufficient information to analyze 
and explain the NMR peaks recorded in the later investigation with microspheres loaded 
with C12H26 and suspended in D2O.  
In next investigation, glass microspheres were loaded with C12H26 according to 





Figure 3.6. Control experiments of different amount of C12H26 added into D2O. a) 1 µL 
C12H26 in D2O. b) 70 µL C12H26 in D2O.  
excess amount of C12H26 from the outer wall of the microspheres according to the 
procedure described in Section 2.4. Afterwards, the microspheres were re-suspended in 
D2O and transferred into a 5 mm NMR tube. The recorded NMR spectrum is shown in 
Figure 3.7. There are three NMR peaks observed in the spectrum, (a) the HOD peak at 
4.63 ppm, (b) the combined peak of all CH2 groups at 1.19 ppm, and (c) the CH3 group 
peak at 0.78 ppm. The triplet splitting of the CH3 group peak is not resolved and the peak 
of the CH2 groups becomes very broad. The broadened peak shapes observed when 
C12H26 is loaded in the microspheres can be caused by several factors, such as changes in 
the relaxation times of molecules inside or outside the microspheres (homogeneous line 







H NMR spectrum of microspheres loaded with C12H26 and suspended in 
D2O. The chemical shift of the CH2 groups was at 1.19 ppm and the CH3 groups at 0.78 
ppm. 
The two common relaxation mechanisms for NMR-active nuclei, i.e., spin-lattice 
relaxation (T1 time constant) and spin-spin relaxation (T2 time constant), are both affected 
by paramagnetic impurities and will ultimately have an influence on the peak width, 
which is inversely proportional to the relaxation observed in the recorded free induction 
decay (FID). For most small molecules, the relaxation times T1 and T2 are about equal 
and long enough so that narrow lines are observed in the NMR spectra. The spin-lattice 
relaxation time T1 of C12H26 was determined from a standard inversion-recovery 
experiment to be T1 = 1.69 s [120], which should be long enough to generate narrow 
peaks. However, since broad peaks are still observed in the NMR spectra of the 
microspheres loaded with C12H26, another effect must be considered which can result in 




homogeneity by substantial susceptibility mismatches between materials. Magnetic 
susceptibility is a measure of the degree to which a material can be magnetized by an 
external magnetic field. As a result of this magnetization, magnetic field lines and with it 
the field’s homogeneity is distorted. The distortion of the magnetic field leads 
inadvertently to peak broadening, which becomes especially visible at the bases of NMR 
peaks. As a result, the significant susceptibility mismatch that exists between the shell of 
the microspheres (-16 × 10
-6
 in SI units) on the one and C12H26 and D2O (-9.06 × 10
-6
 in 
SI units) on the other hand gives rise to the line broadening in the spectra of the loaded 
microspheres. 
Other than the peak broadening, the chemical shifts of the CH2 group peak and 
the CH3 group peak are also changed. In the control experiments, four sets of peaks were 
noticed. As explained previously, the two narrow peaks were assigned to the emulsified 
C12H26 in D2O while the two broad peaks were generated by the phase-separate C12H26. 
The CH2 and CH3 group NMR signals from the C12H26 loaded in microspheres each 
occur with the closest chemical shifts to the emulsified C12H26 signals of the control 
experiments. C12H26 in the microspheres is the template for large colloid, and thus it has 
the same chemical environment with the emulsified C12H26, leading to the same chemical 
shift. This is consistent with the system of CHCl3 and D2O. When the C12H26 molecules 
confined in the microspheres, there is no phase separation, and therefore, the NMR 
signals that have the same chemical shift with the emulsified C12H26 must from inside of 
the microspheres. 
3.3.3. Conclusion. In this model system, the NMR spectra of C12H26 in D2O and 




demonstrate that emulsified C12H26 and phase-separate C12H26 in D2O, which leads to two 
different sets of NMR signals with different line shapes and chemical shifts. The NMR 
signals from C12H26 inside of microspheres lead to peaks with broad bases and same 
chemical shifts with emulsified C12H26. The broad lines are explained by significant 
differences in the magnetic susceptibilities of the glass microspheres on the one and the 
C12H26 and D2O solutions on the other hand. The results show that NMR signals can be 
obtained from the loaded C12H26 inside the microspheres. 
3.4. MATERIAL EXCHANGE FROM THE INTERIOR OF THE 
MICROSPHERES TO THE OUTSIDE  
3.4.1. Inspiration of the Investigation. In the previous section, NMR 
spectroscopy was shown to be powerful to determine materials loaded inside of hollow 
glass microspheres. In the cases described above, materials remain about static in the 
microsphere without a significant exchange from the inside to the outside of the 
microspheres because the chemicals inside and outside were only very slightly miscible. 
Therefore, it is hard for individual molecules to overcome the phase barrier that the two 
individual liquids create through their interphase at the pores of the microspheres. In 
practice, however, drug and biomarker delivery requires the release of the drug or 
biomarker molecules to a target site, which is a dynamic process. Therefore, dynamic (or 
kinetic) NMR information is needed for a comprehensive characterization and evaluation 
of the microspheres as carriers in drug or biomarker delivery systems. 
In the present study, reaction-based methodology was used to investigate the 
exchange of chemicals from the inside of the microspheres to the surrounding solution 




loaded inside the microspheres, while the other reactant is present only in the surrounding 
solution. The formation of a product will lead to the new peaks in the NMR spectra, 
which indicates a contact between the reaction components. The initiation of a reaction 
can only occur if the two chemicals are in close contact within the same medium, which 
requires an exchange of the chemicals inside and outside of the microspheres. A typical 
organic reaction was selected as the model system for studying the exchange of materials 
for several major reasons: (a) inorganic reaction in aqueous solution (such as acid-base 
reactions) are typically very fast and thus don’t provide enough time to monitor the 
occurrence of the exchange on an NMR timescale; (b) 
1
H NMR requires the presence of 
hydrogen atoms, which are more common in organic compounds; and (c) hydrogen 
atoms in inorganic compounds are often in fast exchange with the H2O solvent 
molecules, thus providing no specific peaks in the NMR spectra. In addition, acids can 
propagate from the inside of a microsphere to the outside or vice versa through breaking 
and reforming chemical bonds between hydrogen and oxygen in the aqueous solution 
without requiring physical movement of hydrogen atoms. Therefore, it is difficult to 
determine the occurrence of physical exchange from inside to outside by the observation 
of acid-base reactions (i.e., neutralization reactions). Another reason for choosing organic 
reactions is that most drugs and biomarkers are organic molecules, so that an organic 
molecule based model system is more similar to the projected future applications. In the 
present study, the esterification of isopropanol and acetic acid and its reverse reaction 
(i.e., the hydrolysis of isopropyl acetate) was used as the model system to study the 




3.4.2. Experiments Design and Procedures. The esterification of isopropanol 
with acetic acid reaction (Figure 3.8) was first carried out as a control experiment without 
the microspheres involved. Similarly the hydrolysis reaction of isopropyl acetate was 
conducted in a control experiment. Before conducting the reaction, NMR spectra of 
acetic acid and isopropanol were recorded individually to obtain the chemical shifts of 
each type of proton (Table 1). The esterification was then carried out by mixing 0.1026 g 
of acetic acid (molar mass 60.05 g/mol) and 0.1035 g of isopropanol (molar mass 60.1 
g/mol) in a glass vial. The masses of acid and alcohol compounds were chosen so that the 
mole ratio is 1:1. 100 µL of the mixture were transferred to an NMR tube containing 750 
µL D2O and 5 µL of concentrated H2SO4 as a catalyst. An NMR spectrum was recorded 
immediately after the initiation of the reaction and every two hours after the initiation. 
The last NMR spectrum was recorded after 24 hours. 
The control experiment of the hydrolysis of the esterification of isopropanol with 
acetic acid reaction (Figure 3.8) was carried out by adding 20 µL of isopropyl acetate into 
750 µL D2O in the absence of concentrated H2SO4. After a first NMR spectrum was 
recorded, 5 µL of concentrated H2SO4 was added into the solution, and another NMR 
spectrum was immediately recorded. Further NMR spectra were recorded after 10 





Figure 3.8. The esterification of isopropanol with acetic acid and its hydrolysis reactions. 
Finally, microspheres were loaded with isopropyl acetate according to the 
vacuum-based loading protocol and the washing procedures described in Sections 2.3 and 
2.4. The microspheres loaded with isopropyl acetate were transferred into an NMR tube 
and a spectrum was recorded in the absence of concentrated H2SO4. Then 5 µL of 
concentrated H2SO4 was pipetted into the NMR tube and another NMR spectrum 
recorded after 5 minutes. Again, after 10 minutes, a third NMR spectrum was recorded. 
3.4.3. Results and Discussion. The esterification reaction is a simple organic 
reaction where a carboxylic acid is heated with an alcohol in the presence of a strong 
mineral acid as the catalyst. It usually takes hours to complete the reaction and therefore, 
enough time is provided to monitor the reaction in an NMR spectrometer. Acetic acid and 
isopropanol were selected as the reactants because the chemical-shift difference of the 
CH group between isopropanol and isopropyl acetate is about 1 ppm and thus is easily 
detectable. The high resolution of the two peaks can be used to evaluate the reaction 
progress, which in this case serves as an indicator of the chemical exchange from inside 




carried out by mixing acetic acid and isopropanol at a mole ratio of 1:1 and observing the 
corresponding NMR spectra. The enlarged peak areas are shown in Figure 3.9. Acetic 
acid has a singlet peak at 1.84 ppm, while isopropanol exhibits a septet at 3.76 ppm and a 
doublet at 0.92 ppm. Isopropyl acetate, which is the product of the reaction, shows a 




H NMR spectrum recorded during the esterification of isopropanol with 
acetic acid after adding 5 µL concentrated H2SO4. 
The results (Figure 3.9) indicate that the esterification reaction started 
immediately after 5 µL of concentrated H2SO4 were added, because the peaks of 
isopropyl acetate were already observed less than a minute after the reaction was initiated. 
The septet peak of isopropyl acetate (4.72 ppm) is close to the HOD peak, while the 
singlet peak of the CH3 group in isopropyl acetate (1.81 ppm) and the doublet peak of the 
CH3 group in isopropyl acetate (0.99 ppm) are next to the singlet peak of the CH3 group 
in acetic acid and the doublet peak of the CH3 group in isopropanol, respectively. 




ppm from the septet peak of the isopropanol CH group. The resolution of these two peaks 
can be used as indication for the progress of the esterification, and therefore, the 
occurrence of the two septet peaks is sufficient to show an exchange between the inside 
of the microspheres with the surrounding solution. More NMR spectra were recorded to 
understand the reaction progress, where the NMR spectrum recorded after 24 hours is 
shown in Figure 3.10. However, no significant difference in the peak intensities is 
observed after 24 hours. Esterification reactions typically require temperatures between 
60 – 110 °C, while the reaction rate is very slow at lower temperature. Alternatively, the 
reaction may reach equilibrium very soon after the initiation of the reaction, so that it 
may already be complete after a few minutes.  
Because two chemicals are required to initiate the reaction (isopropanol and acetic 
acid in this case), a problem encountered in this study was which chemical should be 
loaded into microspheres and which into the surrounding solution. The second problem 
occurred around the washing procedure, because acetic acid and isopropanol are soluble 
in both water and chloroform, and it is hard to find an immiscible solvent to wash the 
microspheres loaded with acetic acid or isopropanol. Therefore, the esterification of 
acetic acid with isopropanol was not pursued further in the evaluation of the properties of 
microspheres.  
In contrast, the hydrolysis of esters only requires one reactant (i.e. the ester) and 
the reaction occurs at the same condition as the esterification formation. In addition, 
isopropyl acetate has only a moderate solubility in water, which makes it possible to 
remove excess amounts of loaded chemicals from the microspheres. Moreover, in the 




the septet peak of the CH group was nearly covered by the HOD peak. Peak overlapping 
in NMR spectra makes it difficult to quantify the number of protons of each peak without 
advanced signal deconvolution software and thus results in inaccurate interpretation and 
quantification. In the hydrolysis reaction, however, the focus was on the formation of 
acetic acid and isopropanol, where the latter exhibits a septet peak of the CH group that is 
not only well separated from the septet peak of the CH group of the isopropyl acetate but 
also from the singlet peak of HOD. Therefore, in the results and discussion section, a 




H NMR spectrum of the esterification of isopropanol with acetic acid after 
24 hours. 
The hydrolysis of the isopropyl acetate was evaluated with NMR spectroscopy. 
The first NMR spectrum was recorded as a control experiment with 20 µL of isopropyl 
acetate in 750 µL D2O in the absence of concentrated H2SO4 (Figure 3.11). The septet 
peak of the CH group of isopropyl acetate appears at 4.85 ppm next to the singlet peak of 




peak at 1.93 ppm is assigned to the two isopropyl CH3 groups of the ester, and the 
doublet peak at 1.10 ppm to the acetate CH3 group of the ester. There was only baseline 
noise observed around 3.78 ppm, indicating that no isopropanol has yet been formed. 
Afterwards, the reaction was initiated by adding 5 µL of concentrated H2SO4. Figure 3.12 
shows the NMR spectrum recorded less than a minute after the reaction was initiated. A 
septet peak is observed at 3.78 ppm and assigned to the CH group of newly formed 
isopropanol. This particular peak indicates that the hydrolysis reaction has immediately 
started in the presence of concentrated H2SO4. NMR spectra recorded at the reaction 
times of 10 and 120 minutes (Figure 3.13) reveal that the intensity of the peak 
continuously increases with the reaction proceeding, leading to a higher S/N ratio. This 
indicates the equilibrium for the hydrolysis reaction was not reached even after 120 
minutes. The hydrolysis of the isopropyl acetate proved to be more suitable to evaluate 
the exchange of materials inside and outside of the microspheres. First, isopropyl acetate 
is the only chemical that needs to be loaded into the microspheres thus providing a 
simpler experimental design. Second, the washing procedure can still be applied because 
isopropyl acetate has only a moderate solubility in water. Ultimately and most 
importantly, the NMR spectra are easier to interpret, and the increase in the intensity of 
the isopropanol CH-group septet peak is an indication of the reaction progress. Therefore, 
both the presence and increase of the isopropanol septet peak can be used as evidence for 







H NMR spectrum of the hydrolysis of isopropyl acetate before the injection 




H NMR spectrum of the hydrolysis of isopropyl acetate after the injection 







H NMR spectra of the formation of isopropanol in the hydrolysis of 
isopropyl acetate. The spectrum from bottom up was recorded before the addition of 
concentrated sulfuric acid, directly after the addition of acid, 10 minutes after the addition 
of acid, and 120 minutes after the addition of acid. 
In a second series of experiments microspheres were loaded with isopropyl 
acetate and washed with D2O. Due to the moderate solubility of isopropyl acetate in 
water, the volume of isopropyl acetate injected during the loading process through the 
rubber hose was kept at a minimum and did not completely fill all microspheres. The 
washing of the microspheres was only conducted once to preserve the material inside the 




small amounts of the isopropyl acetate were present in the supernatant, indicating that 
most of the ester was absorbed into the cavities of the microspheres. 
 An NMR spectrum was recorded after the microspheres were suspended in 
750 µL of D2O but in the absence of concentrated H2SO4 (Figure 3.14). No peaks were 
observed at 3.80 ppm, indicating that the hydrolysis had not yet started. A broad peak of 
the CH group of isopropyl acetate was observed at 4.78 ppm, with the resolution of the 
septet peak lost. The doublet of the isopropyl CH3 groups was also not resolved. The low 
resolution is due to the magnetic field distortions caused by the susceptibility differences 
between the shells of the microspheres and isopropyl acetate. Afterwards, 5 µL of 
concentrated H2SO4 was added into the solution and an NMR spectrum recorded within a 
minute after the addition of H2SO4. Figure 3.15 shows the results of the microspheres 
loaded with isopropyl acetate and suspended in D2O in the presence of the concentrated 
H2SO4. A broad peak observed at 3.81 ppm is assigned to the isopropanol CH group, 
which demonstrates the formation of isopropanol. However, the septet resolution of the 
peak is also lost, which indicates that the isopropanol is preferentially formed inside the 
microspheres. Isopropanol formed outside of the microsphere should exhibit a well 
resolved septet. The formation of isopropanol inside the microspheres indicates that H
+
 
propagated into the microspheres and initiated the reaction inside. Nevertheless, an NMR 
spectrum (Figure 3.16) recorded after 10 minutes of adding concentrated H2SO4 shows a 
higher resolution of the CH group peak at 4.78 ppm as well as the CH3 group peak at 3.81 
ppm indicating the presence of isopropyl acetate and isopropanol outside the 
microspheres. Another indication that material exchanged between the cavities of the 




because of the lower density of isopropyl acetate (0.87 g/mL) inside the microspheres 
compared with the D2O in the surrounding solution. By floating to the top, the 
microspheres actually left the NMR-sensitive volume whereas the signals of the 
isopropanol and the isopropyl acetate could still be observed in the NMR spectra. Hence 
the observed signals must be from isopropyl acetate and isopropanol in D2O. The 
increasing peak intensity of the isopropanol CH group indicated that the reaction was still 
proceeding and material was still leaching out of the microspheres. This demonstrated 
that a significant exchange of H
+
 and isopropyl acetate occurred between the inside of the 




H NMR spectrum of microspheres loaded with isopropyl acetate and 







H NMR spectrum of microspheres loaded with isopropyl acetate and 




H NMR spectrum of microspheres loaded with isopropyl acetate and 
suspended in D2O with 5 µL concentrated H2SO4 added. The spectrum was recorded after 




3.4.4. Conclusion. Model studies were conducted with the esterification reaction 
of isopropanol and acetic acid and its reverse reaction of isopropyl acetate hydrolysis into 
isopropanol and acetic acid. A series of control experiments demonstrated that the 
hydrolysis is a more suited reaction for the study of material exchange from the inside of 
the microspheres with the surrounding solution. The formation of isopropanol and the 
presence of a well-resolved septet peak for the CH group of isopropanol showed the 
progress of the reaction. NMR spectroscopy was also able to monitor the proceeding of 
the reaction after the initial injection of the concentrated H2SO4 catalyst. The improving 
resolution of the isopropanol CH-group septet peak along with the progress of the 
reaction indicated that not only H
+
 propagated into the microspheres, but also that 





4. RELEASE KINETICS OF MATERIALS  
4.1. MOTIVATION OF RELEASE KINECTICS STUDIES 
One of the most important aspects during targeted drug or biomarker delivery is 
the controlled release of chemicals at a target site for therapeutic treatments. The 
chemicals should be delivered at a specific rate that is determined by the specific needs of 
the human body or the therapy over a defined period of time. By controlling the release 
of chemicals, it is desirable to maintain the concentration at a constant and lowest 
possible therapeutic level at the target site to achieve a successful treatment without 
causing toxic side effects. There are many types of controlled drug release systems, such 
as encapsulation dissolution controlled systems [121], matrix dissolution controlled 
systems [122], water penetration controlled systems [123], chemically controlled systems 
[124], and others [125-127]. In general, it can be divided into two major categories, 
degradation-controlled system and diffusion-controlled system (Figure 4.1 [128]). 
The degradation-controlled systems function by the release of drugs from a bulk 
phase, in which the drugs are homogeneously dispersed. The drugs are released when the 
matrix is deformed or decomposed. The change to the bulk phase can principally be 
separated into two classes: bulk erosion and surface erosion [128, 129]. Bulk erosion 
refers to a uniform deformation or degradation throughout the bulk of the materials, 
whereas the degradation starts at the matrix surface in the case of surface erosion, and the 
size of the carrier is slowly and uniformly reduced inward. The dissolution rate 
determines the release process of degradation and is highly depended on the degrading 




degradation-controlled system are biodegradable polymers [130]. The first generation of 
biodegradable structures includes polyesters, poly(glycolic acid) (PGA), poly(D,L-lactic 
acid) (PLA), and poly(D,L-lactic-coglycolic acid) (PLGA) [131]. Biodegradable 
polymers have very prominent applications in targeted drug delivery because of their 
biocompatibilities. They can decompose into natural byproducts, such as water and 
carbon dioxide, and thus are easily removed from target sites after they delivered their 
therapeutic payload [132]. Meanwhile, the properties of polymers have major effects on 
the dissolution rate and release behaviors of drug molecules. These parameters include 
crystallinity [133], glass transition temperature [134], hydrophilicity and hydrophobicity 
[135], and molecular weight [136]. Optimization of these properties can largely improve 
the functionality of the polymers as vehicles for drug release. 
The other drug release systems are diffusion controlled, where physical and 
chemical phenomena affect the release rate. The drug molecules must travel through 
tortuous pathways to exit the matrix and diffuse into the surrounding solution. Typical 
diffusion-based drug delivery systems include matrix-based or reservoir-based 
(Figure 4.1). In matrix-based diffusion system, drugs are incorporated into polymers, 
where the swelling effects of the polymers lead to a volume expansion of the system. The 
expansion will cause the opening of pores through which the drug is released. Porous 
poly (lactic-co-glycolic acid) (PLGA)-based microparticles are the most common 
polymers used for matrix-based controlled drug delivery system [132]. The sizes of the 
open pores of the polymer become larger and eventually exceed the size of the drug 
molecules. On the contrary, a reservoir-based diffusion system confines the drug 




[137]. Hence, the PWHGMs used in this study are considered a reservoir-based system. 
The materials to be delivered to a target site are first deposited and confined in the 
microspheres, and then suspended in a miscible solvent environment. The confined 
molecules can pass through the static pores in the walls of microspheres into the 
surrounding environment. Because of its quantitative capabilities, NMR spectroscopy 
provides an opportunity to monitor the release into the surrounding environment by 
observing time-dependent changes in the signal intensities of the released molecules. 
4.2. EXPERIMENT DESIGN AND PROCEDURES 
To observe the release of molecules from PWHGMs to a surrounding 
environment, the procedure exemplified below was developed. It utilizes the unrestricted 
diffusivity and unlimited miscibility of H2O in deuterated water (D2O) but exploits the 
fact that deuterium atoms (
2
H atoms) are invisible in 
1
H NMR spectroscopy. At the same 
time, the D2O can be used for shimming (i.e., homogenizing) the magnetic field and as 
NMR lock solvent. The procedure is as follows: 
1. PWHGMs were loaded with H2O according to the vacuum-based loading 
system described in Section 2.3. 
2. The loaded microspheres were washed three times with CHCl3 according to 
the procedure described in Section 2.4.  
3. A flame-sealed 1-mm capillary tube filled with CHCl3 was inserted vertically 
along the long axis of a 5-mm NMR tube. The integrated singlet signal of 




standard for the integrated peak intensity of the varying H2O peak at 4.63 ppm 
observed in this study. 
4. The microspheres were carefully transferred into the bottom of the NMR tube 
such that the sample height stayed just below the NMR active volume of the 
tube. 
5. D2O was slowly and carefully added into the NMR tube to avoid floating the 
microspheres. 
6.  A series of NMR spectra was recorded in regular intervals for up to 8 hours 
resulting in a total of up to 185 NMR spectra. 
7. The time-dependent, integrated signal intensity of the H2O peak at 4.63 ppm 
was used to quantify the release of material from the microspheres. 
The flame-sealed 1-mm capillary tube filled with CHCl3 provided a time-
independent chemical-shift and signal-intensity calibration for the experiments. The time-
dependent signal intensities of the H2O peak at 4.63 ppm were measured in relation to the 
CHCl3 calibration standard. The microspheres were kept below the NMR-active volume 
so that an increase in the H2O signal intensity is directly attributed to H2O molecules 
released from the microspheres. 
4.3. RESULTS AND DISCUSSION 
NMR is an intrinsically quantitative technique that can be employed for a wide 
variety of applications, among which are in situ monitoring of chemical reactions and 
their kinetics. One of the key advantages of 
1
H NMR spectroscopy over other quantitative 




protons in the NMR-active volume of the sample. Quantitative in situ NMR spectroscopy 
has therefore gained much popularity and attention in the last decades. The quantitative 
aspect of 
1
H NMR spectroscopy was particularly utilized in this study to investigate the 
release kinetics of H2O molecules from the PHWGMs into surrounding D2O. 
The sample height of the microspheres was intentionally kept below the NMR-
active volume as shown in Figure 4.2. The NMR-active volume is the volume where the 
radiofrequency (RF) field of the NMR pulses is delivered to the sample. It is identical 
with the volume in which the RF coil detects the NMR response from the sample. The 
only two chemicals used in this release study are H2O and D2O. However, the D2O that is 
used as the surrounding solution has an intrinsic H2O impurity of about 0.2%. In addition, 
the fast exchange between hydrogen and deuterium in aqueous H2O/D2O solutions leads 
to the formation of mostly HOD molecules. Both species, H2O and HOD, provide a 
singlet peak at 4.63 ppm (Figure 4.3). Therefore, if the microspheres loaded with H2O 
and suspended in D2O were placed within the NMR active volume, it would be 
impossible to differentiate between H2O inside or outside the microspheres. However, 
because the microspheres were placed below the NMR-active volume, only H2O released 
from the microspheres and diffused into the NMR-active volume will increase the 
HOD/H2O signal recorded by the NMR spectrometer.  
Figure 4.3 shows an example of an NMR spectrum recorded during the release 
study using the sample setup illustrated in Figure 4.2. The singlet peak at 7.24 ppm is 
assigned to the CHCl3 confined in the flame-sealed 1-mm central capillary. This signal 
serves as external standard and remains constant during the entire series of NMR 





Figure 4.1. Schematic representation of degradation-controlled (surface erosion, bulk 
erosion) and diffusion-controlled (matrix-based, reservoir based) release systems for 





Figure 4.2 Schematic illustration of the sample distribution in the NMR tube for the 
kinetic release experiment. For this study, the microspheres are kept below the NMR 
active volume.  
intensity during the course of the experiments. The changing intensity of the H2O peak is 
normalized to the intensity of the CHCl3 peak from the capillary tube and plotted as a 




The data plotted in Figure 4.4 represent a double-exponential raise to maximum 
curve as evaluated by a numerical fitting procedure to a 5-parameter double-exponential 
curve leading to the following equation: 
𝐼 = 6.35 + 78% (1 − 𝑒𝑥𝑝  (−0.048 𝑡)) + 22% (1 − 𝑒𝑥𝑝  (−0.0063 𝑡))        (1) 
 
Figure 4.3. A typical 
1
H NMR spectrum recorded during the diffusion process of H2O 
into D2O. 
The best fit to the experimental data is included in Figure 4.4 as a line curve. It has a 
correlation coefficient of R
2
 = 0.9977 and a standard error around 1%. The uncertainty in 
the starting point of the release relative to the first NMR spectrum (± 1 min) adds another 




The curve has a constant intercept, which means that it does not start at zero 
intensity (intercept I0 = 6.35). The intercept represents the 0.2% HOD impurity already 




H NMR signal intensity of HOD/H2O in D2O as a function of time. 
exponential curves, where one applies to 78% (± 2%) of the released H2O and the other 
to the remaining 22% (± 2%). The 78% show a faster release with a time constant of 
about 18 - 20 minutes while the 22% of slower release have a time constant around 160 
minutes. The two different release rates are may result from microspheres with the very 
different pore size distributions. As discussed in Section 2.1, there are two distinct ranges 
of pore sizes, one from 10 nm to 20 nm and another one from 50 nm to 75 nm. Because 




in the microsphere walls largely exceeds the sizes of a H2O molecule. Thus, H2O is 
believed to move freely into and out of the pores. The significant differences in the pore 
sizes, however, still create a different physical barrier to the release of H2O molecules 
into the surrounding solution. Microspheres that have only small pores in the 10 to 20 nm 
range will need much longer to release their material into the surrounding solution. 
Hence, about 78% of the material inside the microspheres is released relatively fast 
through microspheres with large and small pores, while about 22% are released from 
microspheres with only small pores. It has been suggested that the slow release originates 
from material adsorbed on the surfaces of the pores (and the inner surface of the 
microsphere cavity); however, the microsphere shell account for only 5-10% of the entire 
microsphere volume (including the hollow cavity), so that this suggestion is not sufficient 
to explain the slow release of over 20% of the material. Repeating this release experiment 
showed similar results where the optimized curve-fit parameters fall well within the 
standard errors reported above. 
This set of experiments demonstrates that the release time of materials from the 
PWHGMs is largely controlled by the size of the pores in the glass walls of the 
microspheres. This fact can be extremely helpful when designing microspheres as drug 
carries with a desired drug release rate. For example, when the desired release is 
preferred to be slow, the pore sizes must be limited to small openings. On the contrary, 
faster release times are achieved with larger pores. The combination of microspheres with 
only small pores with those that may have small and large pores can even be beneficial in 
combination therapies where an initial boost of medication is desirable for acute 




shown to be a powerful technique to determine release properties of materials deposited 
in PWHGMs. The monitoring of quantitative data obtained from the released material in 
real time can provide information that assists in the design of further refined 






In summary, three major goals were achieved in this dissertation by utilizing 
different analytical techniques to determine biological parameters. The combination of 
using various analytical methodologies has a profound effect on the biomedical studies, 
and thus leads to the future improvement of human health and care. 
In the first paper, a novel dual-core micro-pH probe has been successfully 
developed and fabricated using a home-built double-fiber twisting and gravitational-
stretching system. The probe was coated by a specific OrMoSils dye-doping method and 
applied for pH sensing in a microliter environment. The enhanced mechanical structure 
of the probe with fused double fibers successfully separated the excitation beam and 
emission light, thus providing the robust probe with reduced background noise and 
increased sensitivity. A linear correlation between pH and spectral peak intensity was 
found within a biologically meaningful pH range of 6.20 to 7.92 and a coefficient factor 
of 0.9834 was achieved. The probe’s spatial resolution was then exemplarily tested and a 
resolution of at least 2 mm was clearly demonstrated in a cell + NPs exposure test. We 
finally applied this probe in a TiO2 NP-induced cytotoxicity assay. Results revealed a 
concentration/time dependence of the NP’s cytotoxicity. Results also demonstrated the 
probe’s potential for fast, local and continuous monitoring of cellular events in a staining-
free manner, which may greatly impact future quasi-single-cell and cell-heterogeneity-
driven researches. 
In the second paper, a targeted, quantitative HPLC-MS/MS method was 




gentisic acid and α-ketoglutaric acid in urine, which has not been previously reported to 
the best of our knowledge. The newly developed method was validated by multiple 
conventional figures of merit including method detection limits (0.05 ng/mL to 1 ng/mL), 
spiked recovery studies that indicated high accuracy (88.6% - 114.8%) and 
reproducibility (0.4 – 9.3% RSD), and acceptable intraday variance (1.2% - 2.8% RSD) 
and interday variance (2.4% - 5.1%) The applicability of the newly developed method 
was further demonstrated in 27 urine specimens from healthy individuals in addition to 
several RCC patients. All four compounds were successfully quantified in urine samples 
at concentrations were in agreement with previous findings. Together these findings 
suggest the new method can be considered sensitive, selective, and highly accurate, 
enabling researchers to evaluate the clinical applicability of these four urinary markers 
for earlier RCC detection and diagnosis. Although higher concentration levels in RCC 
samples were observed in our small sample set, larger study populations will be required 
to generate statistically significant conclusions regarding the clinical applicability of 
these four compounds. We therefore anticipate this method to significantly benefit 
clinical researchers aiming to perform epidemiological studies for these four compounds 
and to elucidate their roles in disease. 
In the third part, NMR spectroscopy was applied to characterize materials loaded 
into PWHGMs for applications of microspheres in controlled and targeted drug delivery 
system. It is the first known report of characterizing microspheres and their loaded 
materials with NMR spectroscopy. The information provided by the NMR spectra proved 




Thus NMR spectroscopy is a powerful analytical tool to assist in future designs and 
improvements of PWHGMs as carriers in targeted delivery of drugs or biomarkers. 
Microspheres were first characterized with FESEM. Their proposed spherical 
structure, smooth outer surface, and central hollow cavity were observed and confirmed. 
Under high magnification, different size ranges of the pores in the glass walls of the 
microspheres became visible and quantifiable. The porous structure and hollow cavity of 
the microspheres demonstrated their proposed advantages over other glass materials. A 
vacuum-based loading system was established to fill the microspheres with target 
materials. The loading procedure was shown to be very effective without damaging to the 
integrity of the microspheres. Meanwhile, an effective washing procedure was also 
developed utilizing a solvent that is immiscible with the loaded material. A three-times 
washing process removed all residues of the loading material from the outside of the 
microspheres. NMR spectra of the supernatants confirmed the effectiveness of the 
washing procedures. The established loading and washing procedures were consistently 
applied in the later studies. 
Three model studies were conducted to demonstrate the applicability of NMR 
spectroscopy in the characterization of the PWHGMs intended to be used as drug carriers. 
The first two model studies focused on obtaining NMR evidence of loaded n-dodecane 
and chloroform inside the microspheres. NMR peaks of the loaded materials could be 
distinguished from the peaks of the materials in the surrounding solution, which laid the 
foundation for further studies. A third model study used the hydrolysis of isopropyl 
acetate to provide chemical evidence that material from the inside of the microspheres 




indicator of exchange of isopropyl acetate in the microspheres and concentrated H2SO4 in 
the surrounding solution. These NMR results for the first time provided both static and 
dynamic information of loaded materials in the microspheres. 
The release kinetics of H2O in the cavities of microspheres into the surrounding 
solution of D2O provided further evidence of material exchange between microspheres 
and solution. A 5-parameter double-exponential curve fit of experimental signal intensity 
data as a function of time indicated two release rates with time constants of 18 - 20 
minutes and about 160 minutes. The different release rates are attributed to microspheres 
with a significant difference in the pore size distribution. The results of this study are 
expected to further benefit the design of microspheres as drug and biomarker carriers in 
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